ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036498;IRE1-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;55.46397693329154;5.825829909099042;0.0018563293936187412;0.6210535250702663;[ZBTB17, XBP1, WFS1, EDEM1, SYVN1, ARFGAP1, YIF1A, ERN1, EXTL2, CTDSP2, LMNA, DNAJB11, SSR1, TPP1, HYOU1, SULT1A3]
GO:0035162;embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;36.11381869205153;6.832634648514029;0.0012086970112962418;0.6725415662651573;[KIT, FLT3LG, STK4, SH2B3, STK3]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[USP8, EIF4A3, RAB35, CIB1, BPTF]
GO:0036010;protein localization to endosome;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;32.77360880529348;7.474488534686424;0.001096903192380182;0.7053660038532718;[TMEM30A, RAB35]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[SPHK1, ZFP91, TNFRSF10B, TNFRSF10A, AGER, RELA, RC3H2, NLRP12, IL23A, TLR7, CCL19, LIMS1, HAVCR2]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[CYLD, NLRP12, NLRP3, RELA]
GO:0071380;cellular response to prostaglandin E stimulus;8.0;1.0;0.875;9.628524252492122;704.3614414198233;6.943860283624253;0.023574343560179453;0.7301093378270707;[PTGER4, SFRP1, GNG2, ACACA]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, SFRP1, COL24A1, XRCC5, SIN3A, KIT, HOXB4, PAPD4, MIXL1]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[PPP2CA, DUSP22, DUSP5, CAV1, GPS1, GPS2, DUSP14]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[VAMP8, ITGAV, HLA-A, HLA-F, TAPBP]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[MAP3K3, MAP3K1, TAOK2]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, SMG1, RPL3, RPS7, EIF4A3, RPL23A, PPP2R2A, CASC3, SMG5, PPP2CA, RPS15, SKIV2L, ETF1, DCP1A, RPL29, DCP2, RPL19]
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;7.474488534686424;0.00995955788091634;0.7331650565203278;[PDCD6]
GO:0034063;stress granule assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.069023426578259;0.0035913979925534566;0.7124295520356204;[ATXN2, EIF2S1, PUM2]
GO:1903774;positive regulation of viral budding via host ESCRT complex;8.0;1.0;0.875;9.628524252492122;84.61897092877638;8.67846133901236;0.0028321208048565243;0.8188169164668168;[VPS37B]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[DCLRE1A, CCNK, DCLRE1C, CCNH, MUM1, CIB1, PARK7, ALKBH7, YY1, MYC, EP300, NEK1, GTSE1, AQR, TIPIN, FBXO18, NSMCE2, NEIL3, MSH3, DDIT4, TIMELESS, PAXIP1, COPS7B, COPS7A, XPC, RAD51AP1, NUAK1, CCNB1, RAD21, UBR5, ABL1, USP51, FANCI, XRCC6, UBE2B, XRCC5, INTS3, NONO, CNOT10, CDC7, FANCE, SETX, CDK9, CNOT4, CNOT6, COPS5, NPLOC4, CNOT7, CNOT1, UBE2T, BCL3, CNOT3, CDK2, INTS7, CNOT8, MNAT1, USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, SUV39H1, MCM10, BRCA1, AATF, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP3, CASP2, CTLA4, TOPBP1, RFC5, UPF1, RFC3, RFC4, DTX3L, RFC1, NCOA6, PARP2, RAD23A, TFIP11, MASTL, DDB1, RAD51C, TFDP1, TFDP2, PCNA, PNKP, GPS1, TANK, UNG, TFPT, FZR1, WRN, POLR2B, RBBP5, RNF138, POLR2E, RAD54L, POLR2G, BID, E2F7, E2F8, POLQ, EYA2, GINS4, DONSON, APEX2, GTF2H4, SMUG1, HIST3H2A, RAD51, TTC5, POLE2, RFWD3, TAOK2, POLE3, MNDA, ERCC5]
GO:0048133;male germ-line stem cell asymmetric division;6.0;1.0;0.8231203125901445;9.628524252492122;57.40486638354979;8.390779266560578;0.001921289216831784;0.7522251544931926;[ING2]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP2, NCKAP1, BMPR2, NCF1, ROCK2, ITGB3, PDCD6, ELMO1, NCKAP1L, ITGAV, VAV1, VAV2]
GO:0072334;UDP-galactose transmembrane transport;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;142.06452249237992;9.083926447120524;0.004754771718050423;0.839552420951524;[SLC35A2, SLC35B1]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[BECN1, ERRFI1, BMPR2, EIF4A3, CIB1, LRP8, THBS1, RELA, CLEC3B, BAG4, CCL5, RIPK1, ATP7A, SOX6, EMD, BPTF, TBX1, PDGFRB, USP8, CAV1, CAD, RUNX2, SIRT2, SETX, ERN1, VIL1, SFRP1, EHD4, MARS, RAB35, MT1G, LIMS1]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[VIL1, BECN1, ERRFI1, BAG4, MARS, CAD]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[ESPL1, ZNF207, CDCA8, TUBG1, SMC4, NDC80, ZWINT, NSL1, MAD2L1]
GO:0098989;NMDA selective glutamate receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;28.294234242429713;9.083926447120524;9.469825569365125E-4;0.839552420951524;[SULT1A3]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, ITGB1, IGFBP5, ANGPT1, CD80, PARK7, THBS1, VAV1, PIK3CG, STK3, MTDH, BAG4, C1QBP, KIT, CCL19, TEK, MET, HBEGF]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[FLCN, PDCD6, CIB1, TRIB3, MTM1]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[WDR48, NDUFS6, TBL1XR1, H3F3A, TMED2, CCM2, RC3H2]
GO:0035385;Roundabout signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.50247477320489;7.8311634786251565;8.87013979980389E-4;0.7236063770733796;[MYO9B]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[PDGFRB, ITGB1, GPR55, MYO9B, VAV1, VAV2, BCR, ABR, FLCN, AKAP13, ALS2, ARHGDIB, ABL1, ARHGEF1, ECT2, MET, ARHGEF5]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[ITGB1, FLCN, MET]
GO:0061470;T follicular helper cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.390779266560578;0.01585443403193107;0.8615337942327104;[RC3H2]
GO:1903542;negative regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;247.76337772234075;8.67846133901236;0.008292417279803399;0.8400575416471059;[VPS4B]
GO:1900273;positive regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;146.46287151967024;6.832634648514029;0.004901980501736697;0.7456618788553018;[ADORA2A]
GO:1903543;positive regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;273.97956964224545;7.069023426578259;0.009169849630321672;0.757750811958709;[PDCD6IP, VPS4B, SDC1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CREBBP, BAG4, HSPH1, DNAJC7, BAG3, BAG1, EP300, FKBP4, IER5]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RNF113A, PABPN1, RAVER1, PCF11, U2AF2, POLR2B, POLR2E, DHX16, SNRPB2, POLR2G, SMNDC1, DCPS, SF3B1, RBM5, SPEN, AQR, PRPF38A, RBM15, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, CWC15, LSM5, SRRM1, PRPF4, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0006813;potassium ion transport;7.0;0.7980440201809971;0.7499413753476991;9.310070521373587;34.16983994150393;4.61801832846594;0.001143633791982704;0.587085037334763;[SLC12A2, KCNG1, KCNK6, KCND1, KCNK12, VPS4B, KCNA3, PKD2L1, ATP1B2, PKD2, AQP1, SLC9A6, CDK2, KCNN3, KCNK3]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, WDR1, BRPF3, ITGB3, FGG, RAB27B, THBS1, CLEC3B, LAMP2, CDC37L1, CD9, PHACTR2, FAM3C, CALM1, ALDOA, A2M]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[PTGER4, OXTR, YWHAB, GPS1, IL5RA, GPS2, RASGRP4, PABPN1, CCL5, MYC, CTSH, NCAM1, MBP, RIPK1, ITGAV, HRAS, SULT1A3, PDGFRB, MAP3K3, DUSP5, MAP4K2, MAP3K1, KSR1, ANGPT1, PAQR3, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, KIT, CCM2, KRAS, TEK, CALM1, MET, HBEGF]
GO:0071157;negative regulation of cell cycle arrest;7.0;1.0;0.8509193652572005;9.628524252492122;127.41368125290029;6.641579411751319;0.004264421246666119;0.6905700452391912;[CDK9, CCNK]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[USP8, SEPT11, PDCD6IP, RTKN, KIF23, RHOC, SEPT2, CIT, SPAST, SON, ESPL1, KIF4A, CFL1, RAB35, JTB, CHMP4B, KIF20A, ECT2]
GO:0048025;negative regulation of mRNA splicing, via spliceosome;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;1181.5966005326304;6.781341354126479;0.03954697485192635;0.7620391240755716;[PTBP1, U2AF2, C1QBP, SAP18]
GO:0048024;regulation of mRNA splicing, via spliceosome;9.0;0.811012628672052;0.801746939516315;9.446202695698167;184.4206422322949;5.212725436212633;0.006172392927712444;0.6628196464047262;[RBM3, PTBP1, MBNL1, SON, WTAP, U2AF2, YTHDC1, C1QBP, SAP18, RBM5]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[TFAP2A, PDGFRB, BECN1, ARF4, CDKN1A, CAV1, ITGB2, CTNS, BRCA1, PARK7, AATF, PKD2, THBS1, PARL, SIRT2, FBLN5, BCR, P2RX4, NNT, PTX3, RIPK1, ATG5]
GO:2000270;negative regulation of fibroblast apoptotic process;8.0;1.0;0.875;9.628524252492122;103.9210822679579;7.9853141584524145;0.0034781451006065307;0.7833693374183408;[SFRP1, CFDP1, PIK3CG]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[TNIP2, PIK3C3, TLR7, HAVCR2]
GO:0060134;prepulse inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;45.20359748329822;7.212124270218933;0.0015129237271694644;0.6919486831672181;[ADORA2A]
GO:2001242;regulation of intrinsic apoptotic signaling pathway;8.0;0.6441938053840475;0.6970969026920237;8.974597785085457;108.3214437080355;4.7081694254602375;0.0036254212379377413;0.6157760033703056;[XBP1, FBXO18, RPS7, WFS1, NONO, CAV1, SYVN1, PLAUR, EIF2AK3, PARK7, BCL2L12, CREB3, CYLD, BCLAF1, ING2, HSPH1, UBQLN1, PPIF, VDAC2, PLAGL2, HYOU1, SERINC3, BID, TRIM32]
GO:2000273;positive regulation of signaling receptor activity;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;204.98744489530804;6.311337724880743;0.006860745303922797;0.6736814700148209;[ITGB1, NCF1, CDK5, BUD31, PARK7]
GO:1900045;negative regulation of protein K63-linked ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.593432932680852;696.4444256625374;7.9853141584524145;0.023309368167634688;0.8564896500084854;[UBR5, GPS2]
GO:2000271;positive regulation of fibroblast apoptotic process;8.0;1.0;0.875;9.628524252492122;103.81651994310933;7.8311634786251565;0.0034746454936938316;0.7754860644832351;[SFRP1, BTG1, BID]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[PTGER4, MTPN, CD40, MAP3K1, ITGA2, TNFRSF10B, TNFRSF10A, NFKB1, AQP1, BAG3, NPPA, CASP2, TLR7]
GO:0005978;glycogen biosynthetic process;8.0;1.0;0.875;9.628524252492122;798.0491347435755;6.781341354126479;0.026709986342275536;0.7217981122146513;[PER2, UGP2]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[FGA, EYA2, TRADD, FGG, TNFRSF10B, TNFRSF10A, BRCA1, PARK7, THBS1, RELA, LMNA, RIPK1, ITGAV, BIRC6, RFFL]
GO:2001238;positive regulation of extrinsic apoptotic signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.54514264355307;358.11284317915005;5.8650506222523235;0.011985714580571521;0.6961795867550195;[CYLD, SFRP1, CAV1, G0S2, RIPK1, BID, STK4, THBS1, STK3]
GO:2000144;positive regulation of DNA-templated transcription, initiation;11.0;0.8933024483968273;0.8790801765280758;9.604426700913061;1600.8530134724567;6.444869117505266;0.05357910968674749;0.7620198587159455;[SETX, BCLAF1, PAXIP1, PSMC1]
GO:0051798;positive regulation of hair follicle development;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;137.70877785042182;7.292166977892469;0.004608988864799761;0.6960420709600095;[GAL, TRADD]
GO:0035249;synaptic transmission, glutamatergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.444869117505266;8.61437622431563E-4;0.7045909063862833;[ALS2, CDK5, ADORA2A, SLC1A4]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[HRK, YWHAB, PARK7, STK4, THBS1, BBC3, STK3, BCLAF1, TP53INP1, TP53BP2, CASP2, CTSH, PLAGL2, RIPK1, BID, FBXO18, RPS7, CAV1, ATPIF1, PLAUR, G0S2, YWHAZ, CYLD, SFRP1, TFDP1, TFDP2, ADORA2A, PPIF, SERINC3]
GO:0002042;cell migration involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;27.169092758590633;7.069023426578259;9.093250840340128E-4;0.757750811958709;[ITGB1, EPHB4]
GO:0003252;negative regulation of cell proliferation involved in heart valve morphogenesis;9.0;1.0;0.896240625180289;9.628524252492122;236.79884898870768;9.777073627680469;0.007925444370523912;0.896240625180289;[BMPR2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, VPS29, AHCYL1, RPL3, NUP107, NCF1, PDCD6, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, RAB35, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, HSP90B1, NCKIPSD, VPS11, SSR1, RAB6A, TBC1D15, VPS16, AP1M1, PMM1, RAB3IP, PMM2, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, CD24, ARF3, ARF4, TRAM1, YWHAB, SRP54, CLTA, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TMED7, TNPO2, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:1903724;positive regulation of centriole elongation;12.0;1.0;0.9481203125901445;9.628524252492122;583.3918737387858;9.777073627680469;0.01952560099543789;0.9481203125901445;[VPS4B]
GO:0032924;activin receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.427853557029971;29.903672154863813;6.518977089658987;0.0010008489954655988;0.7083807915285978;[BMPR2]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[PRNP, SLC31A1, ATP7A]
GO:0097720;calcineurin-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;30.117246255164275;7.069023426578259;0.0010079971283984438;0.7365101867784198;[SULT1A3]
GO:0032926;negative regulation of activin receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;236.01143451856106;7.474488534686424;0.00789909031683512;0.7572456912631272;[LEMD3]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TWSG1, BMPR2, RUNX2]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, DDX41, ZC3HAV1, LYST, RELA, NLRP3, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, TLR7, SERINC3, APOBEC3A, EXOC1]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[OXTR, ADORA2A, RAB3GAP1]
GO:0016575;histone deacetylation;9.0;0.7866048967936545;0.7895430735771163;9.396722638434797;357.60632662761185;5.682729065458369;0.011968761927426838;0.6868556538617572;[PER2, HDAC3, BRMS1, HDAC1, TBL1XR1, SIN3A, ARID4A, SAP18, SUDS3, RBBP7, MTA2, SIRT2]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[BCLAF1, FBXO18, RPS7, CAV1, PLAGL2, PARK7, SERINC3, BID]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[TFAP2A, P2RX7, BMPR2]
GO:2000279;negative regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.434368238051164;829.3243434921358;6.166155715036245;0.02775673943322936;0.6903374900225189;[GNL3L, BMPR2, XRN1, NAT10, DCP2]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BCLAF1, PCNA, PAXIP1, FBXO18, DTX3L, EYA2, MYC, CEBPG, TIMELESS, BRCA1]
GO:0035194;posttranscriptional gene silencing by RNA;9.0;0.811012628672052;0.801746939516315;9.405380701177911;180.53772750662347;6.781341354126479;0.006042435266240599;0.7430387373949403;[CNOT6, CNOT7, CNOT1, HELZ, CNOT8, TNRC6A]
GO:0014032;neural crest cell development;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;64.99956039719687;6.558197802812269;0.002175476790687691;0.6256275524841266;[PDCD6, NOLC1, SOX8, KLHL12, KBTBD8]
GO:0035196;production of miRNAs involved in gene silencing by miRNA;10.0;1.0;0.9152410118609203;9.628524252492122;119.55896959962375;7.069023426578259;0.004001531116412497;0.7767511986393403;[ZC3H7A, SNIP1, PUM2]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[STAG1, STAG2, VPS4B, TPR, CHMP4B]
GO:1900220;semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;27.888769134324136;9.083926447120524;9.334120046631251E-4;0.8154717862087246;[SEMA4D]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[BBS2, ARF3, ARFGEF2, ARF4, SYS1, COMMD1, VAMP5, EXOC1]
GO:0006772;thiamine metabolic process;6.0;0.8653626801206646;0.7558016526504768;9.523163736834295;172.32164456529355;8.390779266560578;0.005767450364188875;0.7522251544931926;[TPK1]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[TBP, CSNK2A1, RPS7, SENP2, BCL2L12, BOP1, NUAK1, ING2, TTC5, TP53INP1, CDK2, TRIM24, TP53BP2, EP300, TAF7, TAF5, RFFL, TAF4]
GO:1902527;positive regulation of protein monoubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;610.7263414608234;8.390779266560578;0.020440461030670667;0.8615337942327104;[PDCD6]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[ITGB1, SCARB1, DGKD, TFRC, SH3KBP1, WIPF2, ITGB3, ITGB2, STON1, CLTA, UBE3A, WASL, FNBP1L, RABEPK, PIK3CG, KIAA1109, ITGAV, SCARF1, HRAS, FCER1G, FNBP1, UNC13D, NME1, RUFY1, GAK, ADORA2A, PIK3C3, DOCK2, MET, CSNK1G2, CSNK1G1, COLEC12, CD163L1, LRP8, CORO1A, AGER, TM9SF4, HSP90B1, CLN3, HSPH1, AP2S1, APOL1, AMBP, CAV1, CDC7, MARCH3, MIB1, EHD4, SYNJ1, CDK5, SNX17, CD9, HYOU1]
GO:1901315;negative regulation of histone H2A K63-linked ubiquitination;13.0;1.0;0.9625549647676366;9.628524252492122;2272.1155999244297;8.67846133901236;0.07604566435818852;0.9063718812344532;[UBR5]
GO:0006895;Golgi to endosome transport;7.0;1.0;0.8509193652572005;9.628524252492122;52.5351401021073;6.8867018697843045;0.0017583038606610233;0.7031056191423581;[TGOLN2, DOPEY2, MON2, SYS1]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, SEC13, TRAPPC2L, PDCD6, KLHL12, PPP6C, TFG, TBC1D20, TRAPPC6B, TMED2, STX5, SEC24C]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, ARF4, COPA, DCTN4, PDCD6, GOSR1, DCTN3, KLHL12, TEX261, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED7, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, TRAPPC6B, GOLGB1, HYOU1, SEC24C, SEC22C]
GO:0006646;phosphatidylethanolamine biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;660.9975520457573;7.004484905440688;0.022122993207796184;0.7332096838060964;[CHKB]
GO:0070232;regulation of T cell apoptotic process;9.0;0.7192862368539868;0.7558837436072825;8.8813098506619;22.875998380894767;6.193554689224359;7.656390787466303E-4;0.7129793000169707;[TSC22D4, PRELID1, GPAM, DOCK8, CCL5, PDCD1, GIMAP8]
GO:0048333;mesodermal cell differentiation;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;21.066225782797595;7.138016298065211;7.050676185779127E-4;0.6150384854347593;[ITGB1, ITGB4, ITGB3, ITGA2]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[RAP1B, IGFBP5, ITPR2, PKD2, PIK3CG, AQP1]
GO:0098705;copper ion import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;264.8293356429934;9.777073627680469;0.008863599533042664;0.9324289523296623;[SLC31A1]
GO:0050769;positive regulation of neurogenesis;7.0;0.5833093054345528;0.642574017974477;8.424551448166186;270.7084826640249;3.7179504320986725;0.009060369292947784;0.5410555232571033;[BMPR2, FOXG1, TRAK1, LRP8, AGER, CYB5D2, RELA, RAB21, NCKIPSD, PPP1CC, NIPBL, DVL3, SOX8, ECT2, SCARF1, MARK2, ZNF365, CCR2, SPEN, ACTR2, TMEM30A, SEMA4D, XRCC5, SERPINF1, RAB11A, NME1, SETX, SYNJ1, FES, RHEB, RUFY3, CAPRIN1, KIT, CAMK1, ADNP, TRIM32, PAFAH1B1, EZH2]
GO:0014029;neural crest formation;6.0;1.0;0.8231203125901445;9.628524252492122;35.87688261436843;7.8311634786251565;0.0012007669740048141;0.7236063770733796;[PDCD6, NOLC1, KLHL12, KBTBD8]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, JUP, ROCK2, ZDHHC23, ABCA12, RAB11A, GAK, BAG4, RAB40C, SLMAP, RAB13, TMED2, VAMP5, RAB8B, S100A10]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE3A, BRCA1, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, RC3H2, RNF40, DDB1, KCTD10, MED20, ANAPC5, BIRC6, THOP1, CBLL1, RNF166, HIST1H2BC, ANAPC13, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, MYCBP2, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, RAB40C, MED30, RNF138, UBD, HLTF, UBR5, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, KLHL24, MARCH6, MARCH3, MIB1, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, RFWD3, ASB8, TSPAN17, KBTBD2, CDC16, FBXL3, TRIM32, ASB3, KBTBD8, TRIM33]
GO:1902531;regulation of intracellular signal transduction;6.0;0.4493394816318884;0.5477900534060887;6.766323371562653;41.8512380110395;2.274887141077545;0.0014007232725606145;0.43945814677792094;[ERRFI1, GPATCH3, TFG, MYC, TRIM24, ARL6IP5, HOMER3, IL12A, EPHB4, IER3, CSNK2A1, PAQR3, MAPK8IP3, RC3H2, BCR, DEPDC1B, SFRP1, KARS, IL23A, DDIT4, VDAC2, TRIB3, EPHA1, SEH1L, IL22RA2, MTDH, ABR, NUAK1, RHOT2, RHOT1, HSPH1, RRAS, PRDX1, TP53BP2, A2M, STARD13, XBP1, EIF2AK3, PUM2, CYLD, NPLOC4, ARL2BP, QARS, CALM3, HYOU1, CALM1, CD24, CALM2, EZH2, PIGU, CD40, KIF14, ARHGAP1, OTUD7B, AKAP13, ING2, AKAP11, C1QBP, PBK, HRAS, HAVCR2, TMED4, DUSP5, MAP4K2, SEC13, SPHK1, FCRL3, ZDHHC13, RHOC, GFRA2, VAV1, VAV2, ITPKB, NCOR1, KIT, ARHGEF1, TLR7, ARHGEF5, PAFAH1B1, HBEGF, SLC20A1, GPS1, AKAP7, GPS2, TANK, RELA, ARNTL, PPP2CA, BCLAF1, PLAGL2, CCL19, BID, MAP3K3, MAP3K1, CCL20, RYK, GPR55, SYVN1, MYO9B, BOP1, ITCH, NLRP12, TTC5, TAOK2, LIMS1, NCF1, CD80, PDCD6, CIB1, RORA, UBE3A, PARK7, IGF1R, ARHGDIB, WWC3, EP300, PDGFRB, FBXO18, IGFBP5, RPS7, VRK2, LEMD3, ERN1, RINT1, MADD, PPIF, CARD11, ANKRD17, CLEC16A, AGER, RASGRP4, STK3, MTM1, RAP1B, BCL2L12, ARHGAP21, BAG4, UBD, STK38, ABL1, DVL3, NLRP3, RIPK1, ECT2, FAM83D, PRNP, UBE2I, UBE2B, AMBP, WFS1, NONO, CAV1, TNFRSF10B, TNFRSF10A, ARHGAP25, NFKBIA, IL6, COPS5, CNOT7, RHEB, RCAN3, BCL3, CDK2, SERINC3, ITGB1, TRADD, PTPN22, PKD2, PIK3CG, DUSP14, FLCN, PTBP1, PSD4, NUP62, ITGAV, DACT1, FGA, TBP, KSR1, FGG, PLAUR, ZFP91, SENP2, DUSP22, CREB3, ALS2, MET, BECN1, HDAC3, MGRN1, THBS1, CCL5, TP53INP1, UBQLN1, CSK, ZNF622, RFFL, TBX1, ARFGEF2, PDE6H, ANGPT1, SEMA4D, P2RX7, CD4, P2RX4, PIK3IP1, TNIP2, TAF7, KRAS, SPRY1, TAF5, TEK, TAF4, TRIM32]
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;527.9279232538245;7.379178354882098;0.017669272487020958;0.7523715242355574;[LSM14A]
GO:1900112;regulation of histone H3-K9 trimethylation;11.0;0.8933024483968273;0.8790801765280758;9.52844079393514;105.56354083915117;7.57984905034425;0.003533116710867623;0.8200627852632958;[ZNF274]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, ZBTB20, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, SFMBT2, ZBTB32, SARS, ZNF12, HCFC2, RUNX2, THAP1, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, ZNF274, MAX, FOXG1, MEPCE, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, CBX4, XRCC5, WFS1, BCL11A, NONO, CAV1, H3F3A, NFKB1, CNOT7, CDK5, QARS, YEATS2, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, RCOR3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, TCF25, SUV39H1, CHD8, OTUD7B, BRCA1, LDB2, PTPRK, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, HBZ, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, TFEC, DEPDC1, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, SAP18, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, TRIM33, LIMS1]
GO:0070262;peptidyl-serine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.292166977892469;0.005999310166768488;0.747921758369865;[PPP2CA, PPP2R2A]
GO:0006613;cotranslational protein targeting to membrane;11.0;0.9326813400603323;0.8987696223598284;9.584072489921288;151.34345246524913;5.223196736079928;0.005065329153747539;0.6995434763162781;[RPS15, TRAM1, RPS9, RPL3, RPS7, SSR2, SRP54, SSR1, RPL23A, RPL29, RPL19]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[EBP, TMEM30A, ABCC2, SLC25A19, SLC31A1, ABCB4, ARL6IP5, SLC25A10, SLC36A4, NTSR1, AQP1]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PPP2R2A, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, CCNB1, WEE1, PPME1, CENPJ, CEP70, CDK2, FGFR1OP, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, CEBPG, IL27, TLR7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[ITGB1, CDKN1A, USP37, MAX, GMNN, MCM10, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2C, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, MCM6, MNAT1, MCM2]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[ABCC2, CCL20, CIB1, RORA, BRCA1, THBS1, TANK, NFKB1, RELA, SFRP1, BAG4, CCL5, RIPK1, CCL19]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[OXTR, CCNK, DGKD, GMFB, MAML1, CCNH, DGKA, CD80, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA5, RPS6KA2, MYC, CFL1, TRIM24, NEK1, SEPHS1, EPHB4, PDGFRB, CSNK2A1, PAQR3, ZFYVE21, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, EPHA1, CSNK1G2, CSNK1G1, AK2, ATP5J, AK3, ATP5I, ATP5O, PKMYT1, STK4, RASGRP4, ATP5L, STK3, NUAK1, CCNB1, STK35, STK38, ABL1, STK38L, MBP, RIPK1, CYC1, MARK2, SULT1A3, CHKB, EIF2AK3, DOLK, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, GNPTG, UCK2, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, GPI, CIITA, SMG1, BMPR2, FASTKD1, MAST3, ADPGK, YWHAB, PIK3CG, HK3, AKAP13, ZMYM2, PBK, CTSH, ITGAV, HRAS, DUSP5, MAP4K2, TPI1, KSR1, SPHK2, SPHK1, DCAKD, CAD, BPGM, OXSR1, ATP5F1, MASTL, GFRA2, SPTB, COASY, VAV1, NME1, CIT, GAK, ITPKB, PDIK1L, IMPAD1, KIT, FASTKD5, PIK3C3, ALDOC, TLR7, BIRC6, ALDOA, MET, HBEGF, PRPS2, PTGER4, PDXK, STOML2, ROCK2, PNKP, GPS1, GPS2, COX5B, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, MAP3K1, ANGPT1, AGK, TPK1, GTF2H4, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1, TEK]
GO:2001145;negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.7238800504293;9.777073627680469;0.010566994132243301;0.9152410118609203;[BAG4]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[CNOT4, ITCH, RNF213, UBE2B, DTX3L, UBE2T, UBE3A, BRCA1, KLHL24]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[CYFIP2, NCKAP1, TFRC, WIPF2, GFI1, CD80, GPATCH3, PARK7, RPS6KA5, NPPA, EP300, IL12A, IFNAR2, LAG3, IL4R, HLA-A, HLA-F, UNC13D, RC3H2, BCR, KARS, CD8B, IL23A, PSPC1, ELMO1, CARD11, ANKRD17, PAXIP1, CFH, SUPT6H, AGER, C2, HSP90B1, C3, NCKIPSD, ABR, CLEC7A, ABL1, SLAMF7, NLRP3, NCKAP1L, RIPK1, A2M, HLA-DQA1, ATG5, EIF2B4, PRNP, CREBBP, XBP1, XRCC6, AMBP, CADM1, BTN2A1, XRCC5, NONO, CAV1, PILRB, PILRA, NFKB1, PUM2, NFKBIA, CYLD, IL6, COL1A2, NPLOC4, CNOT7, ARPC2, FES, TREML4, CALM1, HLA-DRB3, CD24, LSM14A, CD200, ITGB1, CUEDC2, CD40, SIGLEC9, C12orf4, ITGB2, ARPC1A, PTPN22, IL27, WASL, FCRLB, AP1G1, SIN3A, C1QBP, CTSH, CTLA4, HRAS, CCR2, HLA-DPA1, HAVCR2, FGA, ACTR2, FCER1G, PVRIG, FCRL3, FGG, BTN3A2, TMEM173, VAV1, VAV2, DUSP22, VAMP8, IRF4, KIT, PIK3C3, LCP2, TLR7, HLA-DQB1, COLEC12, STOML2, GPS2, NLRC4, LILRA2, TANK, RELA, UNG, HLA-DMB, CCL5, UBQLN1, LAIR2, CSK, CCL19, EXOSC3, IL12RB1, NPDC1, MAP3K1, ANGPT1, P2RX7, ITCH, CD4, POLR3B, POLR3C, TNIP2, HLA-DPB1, MNDA, KRAS, C1QC]
GO:2001165;positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues;13.0;1.0;0.9625549647676366;9.628524252492122;1397.7231087839134;9.777073627680469;0.046780534581867456;0.9625549647676366;[CCNK]
GO:1900364;negative regulation of mRNA polyadenylation;11.0;1.0;0.9324289523296623;9.628524252492122;727.4995684895773;7.697632086000634;0.024348755850241696;0.8260862151842345;[CDK9, RNF20, RNF40]
GO:2000074;regulation of type B pancreatic cell development;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;87.86935712531108;7.697632086000634;0.0029409083056968813;0.7167775754447168;[RHEB, ARNTL]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[IFNAR2, CNOT7, LSM14A]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[BTG2, ANGPT1, WFS1, PARP2, NONO, SERPINF1, KIF14, PARK7, CORO1A, CLN3, CDK5, ADORA2A, PSMC1, CHMP4B, KRAS, HYOU1, ADNP, SNCB, HRAS, SULT1A3, CPEB4]
GO:1900246;positive regulation of RIG-I signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;756.7335043639653;7.8311634786251565;0.02532718937512329;0.7967266896635242;[ANKRD17, PUM2]
GO:0060215;primitive hemopoiesis;7.0;1.0;0.8509193652572005;9.628524252492122;36.11381869205014;8.67846133901236;0.0012086970112961952;0.7947362817240173;[STK4, STK3]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNAR2, IRF4, HLA-A, HLA-F]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, USP37, USP38, PPP1R11, USP32, CCNF, USP34, KIF14, BUB1B, UBE3A, UBE2Z, UBE2L3, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP46, USP8, SEC13, RNF44, FBXO18, DTX3L, ARRDC1, RAD23A, VPS37A, TRPC4AP, KCTD5, SIRT2, RNF40, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, USP41, DERL3, VPS4B, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBR5, UBQLN1, USP51, RFFL, RNF20, XBP1, UBE2I, LRRC29, UBE2B, KLHL25, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, CYLD, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, TRIM32, MAD2L1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, CYLD, SFRP1, HDAC1, CAV1, CHD8, DVL3, KLHL12, STK4, EMD, DACT1, STK3]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[PTGER4, OXTR, KARS, MYC, CTSH, ITGAV, SULT1A3]
GO:0006506;GPI anchor biosynthetic process;9.0;0.7980440201809971;0.7952626352707877;9.474373572664863;1288.6226301771758;6.558197802812269;0.04312903974695605;0.7316271658034954;[DPM3, PIGU, PIGA]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PIK3CG, PPP6C, C1QBP, HAVCR2, FGA, MAP4K2, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR7, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CYFIP2, PDCD6, CCNF, PREP, BUB1B, UBE3A, PARK7, UBE2Z, UBE2L3, CNDP2, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, LONP2, PMPCB, SKP2, C18orf25, USP8, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, CDC25A, RNF40, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7B, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, DPP8, UBD, UBR5, NLRP3, USP51, RIPK1, AMZ2, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, MARCH6, PGA5, NFKB1, NFKBIA, NSFL1C, CYLD, COPS5, RNF103, NPLOC4, CDC16, FBXL3, TPP1, USP36, USP37, WDR48, USP38, PPP1R11, USP32, USP34, KIF14, OTUD7B, BRCA1, ECE2, USP39, SENP6, POLB, TRIM9, CTSO, SCRN1, CASP3, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, VPS37A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, MMP23A, PIK3C3, MAN1B1, USP41, THOP1, MPND, BECN1, STOML2, DERL3, GPS1, VPS4B, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, ADAM28, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, P2RX7, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, ASXL2, TRIM32, C1QC, MAD2L1, METAP2]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[VIL1, VASP, NCKAP1, ACTR2, BAG4, ARPC2, WIPF2, ARPC1A, NCKAP1L, WASL, IQGAP2]
GO:0072672;neutrophil extravasation;9.0;1.0;0.896240625180289;9.628524252492122;63.39800827118407;7.9853141584524145;0.0021218742823333786;0.8046099625986299;[PIK3CG]
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;1067.6044110768958;6.599019797332524;0.035731758857152955;0.7527151911823093;[SULT1A1, IMPAD1, SULT1A3]
GO:0039529;RIG-I signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;557.6110095859297;9.083926447120524;0.018662738673513177;0.9271073857191605;[LSM14A]
GO:0036258;multivesicular body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;6.375876246018314;0.0020992917763011008;0.6769819729871445;[PDCD6IP, VTA1, VPS4B, CHMP4B, VPS37A, VPS37B, CHMP6, RAB11A]
GO:0071108;protein K48-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[VCPIP1, USP8, CYLD, USP37, USP34, OTUD7B]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFRB, BECN1, NCF1, ANGPT1, SEMA4D, CCL5, KIT, UBE3A, TEK]
GO:0090611;ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway;7.0;1.0;0.8509193652572005;9.628524252492122;51.84712944745551;8.16763571524637;0.001735276763219217;0.7686126355688037;[PDCD6IP, VPS4B, CHMP4B]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[C1QBP, SIRT2, PIK3CG, IGF1R]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[CD151, FCER1G, TOR1A, ANGPT1, ITGA2, SIRPG, WASL, C2, MIB1, RAB21, BCR, C3, ABR, SYNJ1, PTX3, NCKAP1L, ITGAV, CCL19, DOCK2, CBLL1, SH3GL1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[VPS29, AHCYL1, RPL3, NUP107, TFRC, ZDHHC6, RPS15, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, ARRDC1, COG4, COG3, AP1B1, COG1, MYO7A, SCAMP1, SYTL3, SCAMP3, BCR, RUFY1, NUP93, DOPEY2, UNC50, KIF20A, RPL29, ACOT4, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, SSR1, VPS16, BBS2, XBP1, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, HYOU1, CD24, ARF3, ARF4, TRAM1, AHCTF1, SRP54, ARHGAP1, CLTA, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, TMED7, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, BTN3A2, COMMD1, VAMP8, AFTPH, LSG1, GAL, AGPS, EXOC3, SLU7, VAMP5, PAFAH1B1, EXOC1, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, CCL19, BID, RAE1, RPL19, PEX16, MON2, PEX19, AGK, SYVN1, SNX22, RAB11A, YIF1A, ARCN1, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, TAOK2, RAB3GAP2, APBA3, RAB3B, SYS1, DGKD, NCF1, PDCD6, PARK7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, RPS9, RPS7, VPS33A, VPS33B, TOMM34, TBC1D2B, RINT1, RAB35, CHMP4B, SLC27A2, KPNB1, PPID, CARD11, COPB2, COPA, SUCNR1, HSP90B1, MTM1, NCKIPSD, NLRP3, ECT2, RAB6A, TBC1D15, ATP6V1F, AP1M1, TOR1A, VTA1, NUP153, TIMM44, NFKBIA, PAN3, CDK5, TMEM115, BCL3, SFT2D3, YWHAB, GPR89B, AP1G2, AP1G1, NUP62, ITGAV, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, PDCD6IP, DTX3L, RHBDF2, FGG, TBC1D8, VPS37A, VPS37B, SENP2, ARFGAP1, ACOX2, LCP2, CHMP6, SEC22C, VPS4B, GOSR1, RRBP1, NLRC4, RAB21, AP3M1, RAB20, RAB40C, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, RPL23A, MCM3AP, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;663.4179201744114;5.8650506222523235;0.02220400075087234;0.6961795867550195;[SYNJ1, PIK3C3, PIK3CG]
GO:0014061;regulation of norepinephrine secretion;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;48.7279627950456;6.943860283624253;0.0016308810624307943;0.7301093378270707;[OXTR, ADORA2A]
GO:0051492;regulation of stress fiber assembly;10.0;0.8933024483968273;0.861892236059334;9.4949928598676;106.75891518059157;5.459585514144159;0.0035731248143085707;0.6944444689509434;[PTGER4, SFRP1, BAG4, ROCK2, PPFIA1, ABL1, EPHA1, MET, CLASP1, ARHGEF5, S100A10]
GO:0043620;regulation of DNA-templated transcription in response to stress;10.0;0.6302958089695718;0.7303889163457062;8.89455507741192;277.5670074981562;5.407625775213448;0.009289917946874546;0.6917872454856517;[CREBBP, BCLAF1, EGLN2, BAG3, SIN3A, EP300, ARNT, HIF1AN, SIRT2, RELA]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[DIABLO, BAG3, TRADD, TNFRSF10B, TNFRSF10A, BID]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[BCL2L12, BIRC6, NLRC4, UBE2Z]
GO:0032968;positive regulation of transcription elongation from RNA polymerase II promoter;12.0;1.0;0.9481203125901445;9.628524252492122;3433.0515732151193;6.8867018697843045;0.11490114660968445;0.8003065664753022;[CDK9, ELL, EAPP, SUPT6H]
GO:0051123;RNA polymerase II transcriptional preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;67.28910983117808;6.7325511899570465;0.002252105949782328;0.719302980950052;[TBP, TAF7, TAF4, MED6]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[PIK3CG, CCR2]
GO:1990126;retrograde transport, endosome to plasma membrane;6.0;0.8653626801206646;0.7558016526504768;9.533214072687796;64.06213751966278;6.7325511899570465;0.0021441020906024424;0.6674232935401965;[GRIPAP1, VPS29, SNX17, RAB11A]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN1A, CDKN2C, BMPR2, BTG1, SEMA4D, EI24, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, NPPA, SCGB3A1, RBBP7]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[POLR3B, POLR3C, ZBTB20, TLR7]
GO:0016254;preassembly of GPI anchor in ER membrane;7.0;1.0;0.8509193652572005;9.628524252492122;147.2037350013595;7.069023426578259;0.004926776535734991;0.7124295520356204;[PIGA]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[IL6, IL4R, MBP, TLR7, TRIM32, AGER, HAVCR2]
GO:0030301;cholesterol transport;7.0;0.7763722522362496;0.7391054913753253;8.999915593069748;37.84975072563126;5.845247994956144;0.0012667970942227542;0.6498456195510879;[STARD3, SCARB1, SOAT1, CAV1, VPS4B]
GO:2001168;positive regulation of histone H2B ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.60254876608886;1491.568393434329;8.390779266560578;0.04992145180384398;0.8772251544931927;[CDK9, RNF20, RNF40]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, TRADD, FGG, TNFRSF10B, RIPK1, TNFRSF10A, BRCA1, PARK7, RFFL]
GO:0090503;RNA phosphodiester bond hydrolysis, exonucleolytic;8.0;0.8436909121759173;0.7968454560879586;9.466005322994347;231.13671471601307;6.166155715036245;0.007735937832006836;0.6903374900225189;[CNOT6, PAN3, CNOT7, XRN1, CNOT1, ISG20L2, CNOT8, EXOSC3, DCPS, DCP2]
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;424.7653704329427;6.943860283624253;0.014216514684375884;0.7703503496879909;[SFRP1, STK4, THBS1, STK3]
GO:0045938;positive regulation of circadian sleep/wake cycle, sleep;6.0;0.8933024483968273;0.7697715367885581;9.474373572664863;110.25580931039194;7.8311634786251565;0.0036901627138325927;0.7236063770733796;[ADORA2A]
GO:0038027;apolipoprotein A-I-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;8.16763571524637;8.87013979980389E-4;0.7408135829017477;[ITGB3, ITGAV]
GO:0045815;positive regulation of gene expression, epigenetic;7.0;0.7763722522362496;0.7391054913753253;9.081980546124052;79.85422672196849;5.8650506222523235;0.0026726491042460506;0.6508583268319309;[TBP, WBP2, ATAD2, TAF1A, POLR2E, EP300, POLR1E, DEK, ARID1A, SF3B1]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP2, ITGB1, NCKAP1, TBCCD1, ITGB3, LST1, KIF14, THOC2, STK4, P2RX7, PARVG, VSIG1, TBC1D20, COL4A4, ABL1, NCKAP1L, ITGAV, TEK, ECT2, EPHA1, SOX6, MET]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[BCL2L12, ING2]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, KCNG1, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, PKD2, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PRNP, PDCD6IP, KCND1, FCER1G, TOR1A, GPX3, CAV1, DCXR, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, EHD4, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY, SQLE, EBP, NSDHL, GGPS1]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[TOP2B, BTG2, CDKN1A, BTG1, ZWILCH, BUB1B, BRCA1, PKD2, GPR132, ZNF207, CASP2, EP300, KNTC1, TOPBP1, GTSE1, HRAS, DACT1, TIPIN, TFDP1, RBL1, TFDP2, CTDSP2, MCPH1, PCNA, XPC, CCNB1, RAD21, TPR, ABL1, E2F7, E2F8, FANCI, INTS3, DONSON, MAD2L1BP, CNOT10, ZWINT, CNOT4, CNOT6, CENPF, WEE1, CNOT7, FAP, CNOT1, RFWD3, CNOT3, TAOK2, CDK2, CNOT8, EZH2, MAD2L1]
GO:0051261;protein depolymerization;6.0;0.7192862368539868;0.682763431017138;8.712233520617966;39.9935520007603;6.250713103064308;0.001338548193605436;0.6427820713687392;[VIL1, GAK, KIF19, SYNJ1, WDR1, VPS4B, CFL1, KIF2C, CKAP5, SH3GL1]
GO:0042420;dopamine catabolic process;8.0;1.0;0.875;9.628524252492122;561.0959123607433;7.697632086000634;0.018779375233177315;0.7686572628545723;[MOXD1, COMT, SULT1A3]
GO:0043631;RNA polyadenylation;7.0;0.7980440201809971;0.7499413753476991;9.392135474427892;115.0816327851482;6.221725566191056;0.0038516786825735262;0.6690987000520388;[AHCYL1, CPSF6, PCF11, CPSF3, CPSF2, SSU72, PAPD4, GRSF1]
GO:0021943;formation of radial glial scaffolds;6.0;1.0;0.8231203125901445;9.628524252492122;47.452274261266446;8.390779266560578;0.0015881849152503491;0.7522251544931926;[ITGB1]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[CYFIP2, NCF1, MAML1, GFI1, CD80, CIB1, UBE3A, PARK7, IGF1R, TFG, ARL6IP5, EP300, IL12A, SKP2, EPHB4, PDGFRB, USP8, CSNK2A1, FBXO18, IGFBP5, RPS7, SLC35C2, MAPK8IP3, RC3H2, ERN1, NUP93, DEPDC1B, SFRP1, TWSG1, KARS, IL23A, TBL1XR1, MADD, PPIF, EPHA1, CARD11, ANKRD17, SEH1L, CLEC16A, STK4, AGER, RASGRP4, STK3, MTDH, C3, RAP1B, BAG4, UBD, UBR5, TP53BP2, ABL1, DVL3, RIPK1, ECT2, NTSR1, CREBBP, XBP1, UBE2I, JUP, CAV1, STARD10, TNFRSF10B, TNFRSF10A, NFKB1, PUM2, CYLD, IL6, CDK5, ARL2BP, TREML4, RHEB, CALM3, SERINC3, CALM1, CD24, CALM2, LSM14A, EZH2, CDKN1C, HRK, BCAR3, ITGB1, CD40, BMPR2, YWHAB, ITGB3, TRADD, USP34, ARHGAP1, PTPN22, PKD2, PIK3CG, BBC3, FLCN, AKAP13, PTBP1, ING2, C1QBP, NUP62, CASP2, CTSH, ITGAV, HRAS, DACT1, HAVCR2, TMED4, FGA, DUSP5, MAP4K2, SEC13, KSR1, BUD31, SPHK1, FCRL3, ATPIF1, FGG, PLAUR, ZFP91, ARNT, ZDHHC13, RHOC, YWHAZ, VAV1, ITPKB, DUSP22, TFDP1, ALS2, TFDP2, ADORA2A, KIT, TLR7, MET, ARHGEF5, PAFAH1B1, HBEGF, BECN1, HDAC3, WBP2, SLC20A1, TUBD1, GPS2, THBS1, RELA, ARNTL, BCLAF1, CCL5, TP53INP1, PLAGL2, CSK, ZNF622, CCL19, BID, SH2B3, TBX1, MAP3K3, MAP3K1, PDE6H, ANGPT1, SEMA4D, CCL20, RYK, GPR55, G0S2, FBXL15, P2RX7, CD4, NLRP12, P2RX4, TNIP2, TSPAN17, TAOK2, ASXL2, KRAS, TEK, TRIM32, LIMS1]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[SFRP1, BAG4, ABL1, EPHA1, ARHGEF5, S100A10]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[BECN1, USP36, CALCOCO2, CLEC16A, VPS26B, MTM1, ERN1, CDK5, RHEB, CASP3, ATP6V0A2, CHMP4B, RAB3GAP2, RAB3GAP1, EXOC1]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ITGB1, FCER1G, SYNJ1, TFRC, CAV1, ITGB2, CD9]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[CD40, THBS1, AGER, PIK3CG, AKAP13, DVL3, RIPK1, CSK, CCL19, HRAS, PDGFRB, MAP3K3, DUSP5, MAP4K2, MAP3K1, PDE6H, MAPK8IP3, ERN1, P2RX7, KARS, TAOK2, KIT, MADD, KRAS, CD24, ARHGEF5, EZH2]
GO:0040013;negative regulation of locomotion;4.0;0.5461734764479651;0.5230867382239826;6.9475027237778315;22.159242085956077;4.079980141175065;7.416498905938184E-4;0.45865037415817267;[PTGER4, MCTP1, WASL, PTPRK, THBS1, ABR, FLCN, RRAS, TBXA2R, ADORA3, TP53INP1, ARHGDIB, CLASP1, SEMA6B, RNF20, STARD13, IGFBP5, JUP, SEMA4D, SERPINF1, IDH2, BCR, NISCH, SFRP1, ADORA2A, EPHA1, TRIM32]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[BMPR2, IMPAD1, EIF2AK3, RUNX2]
GO:0042795;snRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1410.6487555617684;5.528578385631111;0.047213144347195396;0.730852068336507;[ZNF143, CCNK, TBP, ELL, INTS3, INTS10, GTF2E2, CDK9, POLR2B, SP1, POLR2E, INTS4, POLR2G, INTS7, TAF5, INTS6, INTS8]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[RUFY1, ARF3, VAC14, DPM3, PIGU, SYNJ1, PLEKHA2, PIGA, PIK3C3, SBF1, PIK3CG, MTM1]
GO:0042311;vasodilation;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;40.37281764308888;6.599019797332524;0.0013512418733372556;0.712474179321389;[BBS2, ADORA2A, ATG5]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, CHD8, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, TEAD2, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, MIXL1]
GO:0045945;positive regulation of transcription by RNA polymerase III;11.0;1.0;0.9324289523296623;9.628524252492122;1460.8767565828284;7.379178354882098;0.04889423033910414;0.8098004765652196;[ELL, CHD8]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[BTG2, ANGPT1, WFS1, NONO, KIF14, PARK7, CORO1A, CLN3, ADORA2A, KRAS, HYOU1, ADNP, SNCB, HRAS, CPEB4]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP2, BTG2, EIF4E3, EIF4A3, CASC3, RBM3, EIF4ENIF1, C1QBP, UPF1, EIF5B, RPS9, IGFBP5, ITGA2, SECISBP2, MIF4GD, ILF3, XRN1, ETF1, EIF4E2, MTPN, POLDIP3, NOLC1, THBS1, FXR1, ATXN2, RXRA, CCL5, TPR, MKNK2, POLR2G, EIF2B4, KLHL25, YTHDF3, EIF2AK3, CNOT10, EIF2S1, PUM2, PER2, CNOT6, IL6, CNOT7, CNOT1, CAPRIN1, BCL3, CNOT3, ACO1, CNOT8, KBTBD8, LSM14A, EIF4G2, TNRC6A, CPEB4]
GO:0006657;CDP-choline pathway;9.0;1.0;0.896240625180289;9.628524252492122;751.2326363803086;7.8311634786251565;0.025143080274170074;0.7967266896635242;[CHKB]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[MED30, CCNE1, UBE3A, BRCA1, ARID1A, FKBP4, PIAS2]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, EI24, VPS4B, VPS37A, VPS37B, DYNLL2, PRKAB1, CLN3, FUNDC1, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, ATG5]
GO:0030643;cellular phosphate ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;422.30099747421934;7.57984905034425;0.014134034339239085;0.7838744581139225;[XPR1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, USP37, WDR48, USP38, USP32, USP12, USP34, OTUD7B, NEDD8, BRCA1, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, TFPT, RHOT1, PSMD7, PSMB5, PSMD4, PSMD2, MYC, PSMB1, NLRP3, USP51, RIPK1, SKP2, USP46, USP8, RAD23A, JOSD1, CDC25A, NFKBIA, CYLD, COPS5, PSMA1, TNIP2, PSMC1, ASXL2, PSME2, USP41]
GO:0042327;positive regulation of phosphorylation;8.0;0.5619039856592722;0.6559519928296361;8.01908634005802;180.92911571624816;2.8593680178451644;0.006055534677390216;0.5212282134068129;[CCNK, NCF1, CCNH, CD80, CIB1, PARK7, IGF1R, RPS6KA4, RPS6KA5, ARL6IP5, NEK1, IL12A, EPHB4, PDGFRB, FBXO18, FLT3LG, MAPK8IP3, ERN1, TWSG1, KARS, IL23A, MADD, JTB, MTCP1, ADNP, EPHA1, STK4, AGER, STK3, C3, RAP1B, CCNB1, BAG4, HSPH1, ABL1, DVL3, NCKAP1L, RIPK1, ECT2, MARK2, PRNP, XRCC6, XRCC5, CAV1, GLMN, TNFRSF10B, TNFRSF10A, PILRB, CDK9, CCDC88A, IL6, EHD4, CDK5, ARL2BP, CALM3, CALM1, MNAT1, CD24, CALM2, EZH2, BCAR3, CDKN1A, CD40, BMPR2, ITGB3, KIF14, PTPN22, PKD2, PIK3CG, CKS1B, FLCN, AKAP13, ITGAV, HRAS, HAVCR2, FGA, DUSP5, MAP4K2, KSR1, SPHK1, FCRL3, FGG, PLAUR, ZFP91, ARNT, OXSR1, SENP2, GFRA2, VAV2, DUSP22, ALS2, KIT, LCP2, MAPRE3, MET, ARHGEF5, HBEGF, VAC14, HDAC3, ROCK2, ITLN1, LRP8, THBS1, PPP2CA, KCTD20, CCL5, CSK, ZNF622, CCL19, TBX1, MAP3K3, MAP3K1, PDE6H, ANGPT1, SEMA4D, CCL20, RYK, GPR55, P2RX7, CENPE, CD4, TAOK2, CDK2AP1, KRAS, CAMK1, TEK]
GO:0045715;negative regulation of low-density lipoprotein particle receptor biosynthetic process;8.0;1.0;0.875;9.628524252492122;494.7516452988549;8.67846133901236;0.016558892320579825;0.8188169164668168;[ITGB3, ITGAV]
GO:0014057;positive regulation of acetylcholine secretion, neurotransmission;9.0;1.0;0.896240625180289;9.628524252492122;1157.9374882930474;9.083926447120524;0.038755125657086144;0.8607930461318132;[ADORA2A]
GO:1902188;positive regulation of viral release from host cell;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;120.05257821018927;7.069023426578259;0.004018051752389216;0.7365101867784198;[DDB1, VPS4B, CHMP4B, VPS37B]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[CD40, NCF1, CIB1, PTPN22, PIK3CG, IGF1R, AKAP13, ARL6IP5, ITGAV, HRAS, EPHB4, HAVCR2, PDGFRB, FGA, DUSP5, MAP4K2, KSR1, FCRL3, FGG, MAPK8IP3, ERN1, DUSP22, KARS, KIT, MADD, EPHA1, MET, ARHGEF5, THBS1, AGER, STK3, RAP1B, CCL5, ABL1, DVL3, RIPK1, CSK, ZNF622, CCL19, TBX1, MAP3K3, MAP3K1, PDE6H, ANGPT1, CCL20, RYK, GPR55, P2RX7, CD4, IL6, TAOK2, KRAS, TEK, CD24, EZH2]
GO:0030514;negative regulation of BMP signaling pathway;12.0;0.8259837884571596;0.8611122068187244;9.4949928598676;599.3292772798114;5.905872616772578;0.02005901154922404;0.7501469128630576;[SFRP1, TWSG1, ABL1, LEMD3, TRIM33]
GO:0030513;positive regulation of BMP signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.571365838652174;514.640204837359;6.311337724880743;0.017224544509792043;0.770882417347765;[TWSG1, BMPR2, FBXL15]
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;6.7325511899570465;0.010250602759086841;0.719302980950052;[HIST1H2BJ, GPS2, RFFL]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[CYLD, HIST1H2BJ, SPHK1, TRADD, MADD, GPS2, RIPK1, RFFL, TRIM32]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[ONECUT2, SNX25, CAV1, LEMD3, GLG1]
GO:0030511;positive regulation of transforming growth factor beta receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;345.4564576873422;6.518977089658987;0.011562116748168153;0.7083807915285978;[CDKN1C, FLCN, ING2, THBS1]
GO:0014049;positive regulation of glutamate secretion;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;414.8970628992697;7.474488534686424;0.013886231312124032;0.7784863164434164;[P2RX7, ADORA2A, NTSR1, RAB3GAP1]
GO:0006361;transcription initiation from RNA polymerase I promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.311337724880743;0.015969835568764485;0.7190027299379095;[TBP, CCNH, TAF1A, POLR2E, POLR1E, MNAT1, GTF2H4]
GO:0007212;dopamine receptor signaling pathway;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;26.976932752798508;6.166155715036245;9.028936615729279E-4;0.6384578026126634;[GNG2, GNAQ, SULT1A3]
GO:1901026;ripoptosome assembly involved in necroptotic process;6.0;1.0;0.8231203125901445;9.628524252492122;41.11586962729703;9.083926447120524;0.0013761111545453324;0.7876727335416686;[CYLD, RIPK1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ZNF175, CCNK, BMPR2, ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, MYC, TRIM24, ZNF768, EP300, IER2, GTF2I, KLF11, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, RFX4, TFEC, MED20, LCOR, WBP2, MAX, CEBPG, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, POLR2E, HOXC4, ZBED1, PLAGL2, POLR2G, HIVEP2, TCFL5, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, NFIA, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, INTS7, TAF5, INTS6, MNAT1, TAF4, ZNF136, INTS8, NFE2L1, MIXL1]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[SETX, TIAL1, PTBP1, POLR2B, POLR2E, POLR2G, SHCBP1]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[DPAGT1, ST6GAL1, PMM1, DERL3, RPN1, PMM2, SYVN1, FUT8, DOLPP1, MGAT4B, STT3A, PGM3, MGAT3, MGAT1, B4GALT7]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[RIC8A, ITGB1, CDK5, KIT, DDHD2, CTNS, KRAS]
GO:0006363;termination of RNA polymerase I transcription;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.343086423195323;0.015969835568764485;0.7206263598461826;[TBP, CCNH, TAF1A, POLR2E, POLR1E, MNAT1, GTF2H4]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS9, WDR37, DDX27, RPS7, POP4, SUV39H1, WDR18, EIF4A3, HEATR1, ISG20L2, NOLC1, NAT10, IMP4, WDR43, BYSL, RRP9, RPS15, BOP1, LAS1L, RPL7L1, PES1, MRTO4, EXOSC3]
GO:0098780;response to mitochondrial depolarisation;4.0;0.811012628672052;0.655506314336026;9.223059144383958;28.997869804256865;6.832634648514029;9.705326059599744E-4;0.5994212536750128;[BECN1, ATPIF1, GPS2]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CDKN1A, MAML1, CCNH, RORA, ZNF45, GTF2E2, RXRA, MED30, POLR2B, NPPA, POLR2E, POLR2G, TEAD2, GTF2I, CREBBP, TBP, GTF2H4, MED6, RUNX2, CDK9, MED20, TAF7, TAF5, MNAT1, TAF4]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CDK9, CCNK, ELL, POLR2B, CCNH, EAF2, POLR2E, POLR2G, MNAT1, SUPT6H, GTF2H4, AFF4]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[VPS29, CHD8, USP34, KLHL12, APCDD1, GNG2, GNAT2, RNF138, MYC, AP2S1, DVL3, MARK2, DACT1, TLE4, CSNK2A1, UBE2B, RYK, SENP2, DDB1, CYLD, SFRP1, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ARFGEF2, FCER1G, IL23A, ZBTB20, RIPK1, CCL19, THBS1, CCR2, HAVCR2]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[SCARB1, CD151, MCTP1, SIRPG, STON1, WASL, C2, RAB21, C3, ABR, ATXN2, RAB20, AP2S1, ABL1, NCKAP1L, CSK, ITGAV, CCL19, SH3GL1, ATG5, FCER1G, TOR1A, ANGPT1, ITGA2, CAV1, ARFGAP1, MIB1, BCR, RUFY1, EHD4, SYNJ1, SNX17, PTX3, DOCK2, SMAP1, CBLL1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[CCNB1, RAD51C, SIN3A, RCC2, VPS4B, CDC7, RAB11A, CDC25A]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, GALNT11, SEPT11, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, SEPT2, TMEM138, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:0006370;7-methylguanosine mRNA capping;10.0;1.0;0.9152410118609203;9.628524252492122;354.47150569988446;6.250713103064308;0.011863842292131473;0.734902770639515;[POLR2B, CCNH, POLR2E, POLR2G, MNAT1, GTF2H4]
GO:0006376;mRNA splice site selection;7.0;0.8653626801206646;0.7836007053175329;9.533214072687796;66.59596265062147;6.343086423195323;0.002228906937441061;0.6753050999230941;[SETX, YTHDC1, SLU7]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[NSDHL, CENPJ, IFT122, PKD2L1, SEPT2]
GO:0006011;UDP-glucose metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;147.32279532564462;8.16763571524637;0.0049307613776414785;0.7686126355688037;[UGDH, UGP2]
GO:1903215;negative regulation of protein targeting to mitochondrion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;662.3781059989874;7.9853141584524145;0.022169199106192902;0.8236103492792612;[BAG4, BAG3]
GO:0006012;galactose metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.0689084645567;34.676020684410545;7.069023426578259;0.0011605752059146955;0.6846304993685643;[SLC35A2]
GO:0042986;positive regulation of amyloid precursor protein biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;886.5971894629109;9.083926447120524;0.029673610045656235;0.8607930461318132;[SOAT1]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[CSTA, CASP3, STK4]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[SPEN, GALNT11, ITCH, CREBBP, MAML1, PERP, MYC, NOTCH2NL, EP300, DTX2, MIB1]
GO:0070197;meiotic attachment of telomere to nuclear envelope;6.0;1.0;0.8231203125901445;9.628524252492122;47.87223991037342;7.697632086000634;0.0016022407875814137;0.7167775754447168;[LEMD3]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[ZNF175, CCNK, MAML1, CCNH, GFI1, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SECISBP2, FLT3LG, PRKAB1, MED6, RUNX2, SFRP1, KARS, IL23A, RFX4, HOXB4, PAXIP1, NOLC1, C3, FXR1, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZBED1, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, NIPBL, ING2, C1QBP, TMED2, CTSH, HRAS, TEAD2, ZNF485, SEC13, NCOA6, TMEM173, PPRC1, SIRT2, GNL3, NCOR2, GAL, NCOR1, MTF2, TFEC, KIT, MAPRE3, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, LMNA, PLAGL2, GPBP1L1, SF3B1, ZNF462, YTHDF3, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, RAB3GAP1, MIXL1, LIMS1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, EP300, ZNF564, RPS9, RPS7, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, CCNB1, MED30, UBR5, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, RHBDD1, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CIITA, BMPR2, ONECUT2, CHD8, PTPN22, DDX41, LDB2, PKD2, CKS1B, RBM3, FLCN, LBH, SIN3A, NUP62, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, ITGA2, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, POLR1E, EAPP, MET, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, CEBPG, THBS1, CLEC3B, U2AF2, TP53INP2, CCL5, TP53INP1, TAF1A, POLR2E, POLR2G, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, DEK, USF2, P2RX7, CD4, TNIP2, ASXL2, TAF7, KRAS, FAM98A, TAF4]
GO:0071044;histone mRNA catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.60383163990175;834.8214523265239;7.292166977892469;0.027940722718839572;0.7881627702307852;[UPF1, XRN1, PAPD4, DCP2]
GO:0033962;cytoplasmic mRNA processing body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.212124270218933;0.0035913979925534566;0.7197477358342742;[ATXN2, CNOT7, LSM14A]
GO:0010742;macrophage derived foam cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.8311634786251565;7.282666309192915E-4;0.6907270763441554;[SOAT1, EP300]
GO:0032510;endosome to lysosome transport via multivesicular body sorting pathway;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;127.43112785876568;8.390779266560578;0.004265005168863507;0.7800242071602487;[VPS4B, LYST]
GO:0010745;negative regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;114.21841186311113;7.212124270218933;0.0038227874551613377;0.6919486831672181;[NFKBIA, ITGB3, ITGAV]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[P2RX7, IL6, XBP1, FCER1G, ZBTB20, MBP, TLR7, TBC1D23]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, STK38, MKNK2, STK38L, RIPK1, MARK2, EIF2AK3, CDC7, VRK1, VRK2, MASTL, CLK1, ERN1, CDK5, CAMK4, CDK2, CAMK1, CSNK1G2, CSNK1G1]
GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;7.0;0.811012628672052;0.7564256795932265;9.318369324188282;71.23621840810117;5.132682728539097;0.0023842121216848507;0.6134049986888465;[CDKN1C, FLCN, ING2, ONECUT2, SNX25, CAV1, LEMD3, THBS1, GLG1, TRIM33]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TWSG1, BMPR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CXCL6, SCARB1, GPI, CD40, BMPR2, ONECUT2, DOCK8, ITGB3, PDCD6, CIB1, IGF1R, NIPBL, C1QBP, CTSH, IL12A, ITGAV, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, IGFBP5, ITGA2, SPHK1, SWAP70, PTP4A1, CREB3, KARS, IL23A, RUFY3, KIT, EPHA1, MAPRE1, MET, CBLL1, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, BAG4, CCL5, ABL1, NCKAP1L, CCL19, CLASP1, MAP3K3, XBP1, ANGPT1, SEMA4D, CCL20, RAB11A, VIL1, IL6, P2RX4, SP1, FGFR1OP, TEK, TRIM32]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[POLE4, DR1, CRTC2, YEATS2, IRF4, BRPF3, POLE3]
GO:0061036;positive regulation of cartilage development;6.0;0.8259837884571596;0.7361122068187242;9.36615998802463;85.07595514026741;6.375876246018314;0.00284741565515604;0.6491829203200885;[BMPR2, SOX6, RUNX2, RELA]
GO:0045906;negative regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.582004236857228;143.99886387479756;7.8311634786251565;0.004819512383325719;0.7754860644832351;[BMPR2]
GO:1902017;regulation of cilium assembly;8.0;0.7866048967936545;0.7683024483968273;9.34084218004034;85.2089877911262;5.926926025970411;0.002851868138258671;0.6781032725983739;[CCDC88A, CYLD, CENPJ, VDAC3, EVI5L, ATG5]
GO:1904556;L-tryptophan transmembrane transport;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;435.1879830171803;9.777073627680469;0.014565350147827973;0.9324289523296623;[SLC36A4]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, CCNK, GMFB, MAML1, CCNH, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA5, RPS6KA2, MYC, CFL1, TRIM24, NEK1, EPHB4, PDGFRB, CSNK2A1, PAQR3, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, EPHA1, CSNK1G2, CSNK1G1, PKMYT1, STK4, RASGRP4, STK3, NUAK1, CCNB1, STK35, STK38, ABL1, STK38L, MBP, RIPK1, MARK2, SULT1A3, EIF2AK3, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, SMG1, BMPR2, FASTKD1, MAST3, YWHAB, PIK3CG, AKAP13, ZMYM2, PBK, CTSH, ITGAV, HRAS, DUSP5, MAP4K2, KSR1, CAD, OXSR1, MASTL, GFRA2, SPTB, CIT, GAK, ITPKB, PDIK1L, KIT, FASTKD5, PIK3C3, TLR7, BIRC6, MET, HBEGF, PTGER4, ROCK2, GPS1, GPS2, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, MAP3K1, ANGPT1, GTF2H4, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1, TEK]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[BECN1, ZNF175, CD40, DDX41, ZC3HAV1, LYST, RELA, CCL5, CFL1, NLRP3, IL12A, CCL19, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CDK6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, BCL3, POLR3E, DDIT4, TLR7, SERINC3, LSM14A, APOBEC3A, XPR1, EXOC1]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[CDKN1C, ERRFI1, CDKN1A, GMFB, GPS1, GPS2, CIB1, PTPN22, PARK7, DUSP14, IGF1R, PPP2CA, CASP3, NUP62, STK38, ABL1, DUSP5, CDKN2C, CAV1, PAQR3, DUSP22, SFRP1, CDK6, QARS, ADORA2A, GNAQ, PKIA, TAF7, FGFR1OP, CRIPAK, TRIB3, SPRY1, EPHA1, CHMP6]
GO:0030326;embryonic limb morphogenesis;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;43.30626768056369;5.395046993006588;0.0014494218061579028;0.5661439659786197;[TFAP2A, NIPBL, MBNL1, IFT122, RUNX2]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[XRCC6, FBXO18, XRCC5, CHD8, GINS4, CHD1, GTF2H4, SETX, WRN, RAD51, ASCC3, MCM6, MCM2]
GO:0032509;endosome transport via multivesicular body sorting pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;62.963525230995856;6.599019797332524;0.002107332525987629;0.6605944919115335;[VPS4B, VPS37A, VPS37B, LYST]
GO:0010710;regulation of collagen catabolic process;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;24.935744707516132;8.67846133901236;8.345769346473027E-4;0.7340579283277371;[ITGB1, FAP]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[SFRP1, UBE2B, RYK, MYC, CHD8, DVL3, SDC1]
GO:0019544;arginine catabolic process to glutamate;11.0;1.0;0.9324289523296623;9.628524252492122;698.4521964292683;9.777073627680469;0.023376566448320795;0.9324289523296623;[OAT]
GO:1903351;cellular response to dopamine;8.0;1.0;0.875;9.628524252492122;545.6259493406901;7.138016298065211;0.018261609492958953;0.7400384854347593;[SIN3A, ABL1, SULT1A3]
GO:0006471;protein ADP-ribosylation;7.0;0.7980440201809971;0.7499413753476991;9.245532000236016;151.15475272427284;6.641579411751319;0.005059013543235805;0.6905700452391912;[ARF4, PARP2, SIRT2]
GO:0038044;transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[ITGAV]
GO:0044828;negative regulation by host of viral genome replication;9.0;1.0;0.896240625180289;9.628524252492122;287.7494343559507;8.16763571524637;0.009630714610215706;0.8139338954918922;[CCNK]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, ZNF18, SAP30BP, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, EID1, EWSR1, RFX4, HOXB4, TRIB3, ASF1B, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, ZNF101, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, BMPR2, ONECUT2, CHD9, CHD8, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TCFL5, TBX1, POLR2J3, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, TRIM33]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PTPN22, PPP2R2A, PTPRK, PPM1G, DUSP14, MTM1, PPP1CB, PPP2CA, PPP1CC, PPP6C, PDPR, SBF1, DUSP5, EYA2, SSU72, DUSP28, PPP2R5D, SSH3, CDC25A, PTP4A1, DUSP22, DUSP23, MINPP1, UBLCP1, PTPRA, CTDSP2]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[ZNF175, NUP107, MAML1, GPATCH3, ELK1, MYC, ZXDC, IER5, IER2, ZNF18, SAP30BP, CSNK2A1, ZNF282, RFX1, ZNF12, HCFC2, SND1, MED6, RC3H2, EID1, EWSR1, RFX4, HOXB4, ASF1B, ZNF276, ZNF395, ZNF274, ZNF394, MEPCE, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, RAD21, HESX1, HOXC4, ZNF264, ZNF143, CREBBP, ZNF263, JUP, ZNF260, H3F3A, PBX3, EIF2AK3, ERLIN2, ZNF35, FLI1, SOX30, SETX, CYLD, QARS, PKIA, ZNF30, ZNF136, EZH2, CDKN1C, SETD5, ARF4, BTG2, CDKN1A, SETD3, BTG1, ELL, ZNF250, TCF25, ATF7IP2, HOXC13, ZNF45, WDR43, NIPBL, CHAF1B, ING2, CIC, JARID2, TEAD2, HAVCR2, ZNF485, BRD3, HELLS, SPHK1, BAZ1A, TMEM173, MED29, SIRT2, MED28, GNL3, NCOR2, NCOR1, MTF2, MED20, ZNF350, GPS2, ZNF69, BCLAF1, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, ATAD2, GTF2H4, CENPF, NFIA, NFIB, NFIC, PSMC1, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, NCF1, NAB1, GMNN, UBP1, ZBTB20, RORA, YEATS4, PARK7, YY1, ADORA3, ZNF207, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, ILF3, ADNP, ZNF550, MAX, RLF, GTF2E2, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, DVL3, ZNF544, TRAPPC2, ZBTB17, DR1, WFS1, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CDK5, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, CIITA, BMPR2, ONECUT2, TRADD, ITGB2, LBH, SIN3A, ZNF407, ZNF768, ZNF525, ZNF524, ZNF766, HIF1AN, PEG3, DTX3L, RFC1, ZFP91, ARNT, ZFP90, DUSP22, TFDP1, ZNF519, TFDP2, ADORA2A, LCOR, ZNF511, MET, ZNF630, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, RBBP5, DNAJB5, TP53INP2, TP53INP1, SAP18, ASCC3, ZNF622, RBBP7, E2F7, E2F8, IRX1, TBX1, RNF20, SEMA4D, FBXL15, POLR3C, ASXL2, MNDA, TRIM32, TRIM33, TCERG1, CCNK, CCNH, GFI1, IKZF1, IKZF2, UBE2L3, TIAL1, RPS6KA4, RPS6KA5, SAP130, DPF2, TRIM24, SOX8, FBXO5, SOX6, SFMBT2, FLT3LG, RUNX2, THAP1, THAP6, SFRP1, TWSG1, KARS, IL23A, BOLA3, TRIM14, TRIB3, ANKRA2, PAXIP1, FOXG1, MYCBP2, GMCL1, COMMD9, HLTF, HIVEP1, SCAP, ZBED1, HIVEP2, XBP1, XRCC6, SETDB1, XRCC5, BCL11A, EAF2, STAG1, GOLGB1, RCOR3, AHCTF1, CD40, SUV39H1, OTUD7B, BRCA1, WASL, PTPRK, AATF, ZMYM2, SCML1, C1QBP, HRAS, TSC22D4, HBZ, SEC13, NCOA6, PRMT3, TSC22D2, COMMD3, COMMD1, PPRC1, ZFX, VAV1, TOX4, GAL, NFX1, TFEC, KIT, DEPDC1, MAPRE3, VGLL4, ARHGEF5, PCNA, HEATR1, NEDD8, ZNF2, TRAK1, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, SERTAD2, TCEAL3, GPBP1L1, SCAND1, NFYC, GRHL1, PER2, ITCH, NLRP12, GFI1B, HIST3H2A, TTC5, CAMK4, MARS, CAMK1, CRTC2, CD80, ARID4A, CIB1, UBE3A, WWC3, EP300, SNIP1, SSU72, ERN1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, PPID, CARD11, SUPT6H, AGER, STK3, NLRP2, NLRP3, RIPK1, CYTL1, SUDS3, BPTF, TFAP2A, PRNP, UBE2I, CBX4, NONO, CAV1, CNOT10, NFKBIA, IL6, ZSCAN2, PHF19, USP36, PHTF2, YWHAB, CHD9, CHD8, DDX41, LDB2, PKD2, CHD1, AFF4, CKS1B, FLCN, NUP62, GATAD1, LRRFIP1, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, BUD31, MKL1, SENP2, SAFB, ARID1A, CREB3, RBL1, SETBP1, ELF4, IRF4, EAPP, ITGB3BP, MCPH1, TFPT, FAM120B, TAF1A, MTA2, ZNF189, TCFL5, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, CD4, TNIP2, TAF7, KRAS, TAF5, TAF4]
GO:0000921;septin ring assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.16030555582066;7.069023426578259;0.003586558988939603;0.7124295520356204;[SEPT11, SEPT2]
GO:0006479;protein methylation;8.0;0.5860072649471136;0.6680036324735568;8.391761625343195;206.79845698774034;4.917261223318797;0.006921358248851439;0.6264689676365554;[RAB3B, BTG2, SETD3, PAXIP1, BTG1, SETDB1, SUV39H1, PRMT3, ARID4A, RLF, RBBP5, IRF4, ETF1, FAM98A, RAB6A, PCMTD1, EZH2]
GO:0007205;protein kinase C-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.444869117505266;9.028936615729279E-4;0.6527112189764278;[DGKD, ADORA2A, DGKA]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, CCNK, MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, IER2, ZNF18, ZNF282, FLT3LG, RFX1, ZNF12, HCFC2, MED6, RUNX2, RC3H2, THAP1, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ANKRA2, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, JUP, ZNF260, BCL11A, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, RCOR3, ZNF136, EZH2, ARF4, AHCTF1, BTG2, CDKN1A, CD40, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, NIPBL, ZMYM2, C1QBP, CIC, JARID2, HRAS, TEAD2, HAVCR2, ZNF485, BRD3, TSC22D4, HBZ, NCOA6, TSC22D2, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, ZNF350, GPS2, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, ZBTB20, RORA, YEATS4, UBE3A, PARK7, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, BMPR2, ONECUT2, CHD8, DDX41, LDB2, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, ZNF511, EAPP, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, SAP18, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, TBX1, SPEN, SEMA4D, FBXL15, ARID3B, DEK, USF2, TNIP2, ASXL2, TAF7, TAF4, TRIM33]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[PTGER4, OXTR, CAV1, SWAP70, GPR55, ITPR2, PKD2, PIK3CG, P2RX7, CD4, P2RX4, GNAT2, TBXA2R, ABL1, CALM3, ITGAV, CCL19, CALM1, CD24, CALM2, NTSR1, CCR10, CCR2]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT12, GALNT11, ST6GAL1, GALNT1, GALNT10]
GO:0030433;ubiquitin-dependent ERAD pathway;10.0;0.9326813400603323;0.8815816818910864;9.600353375525426;603.0491029665483;5.557565922504363;0.02018351076733335;0.6994551915910392;[SEC13, WFS1, EDEM1, DERL3, SYVN1, DERL2, ERLIN2, MARCH6, HSP90B1, RNF103, NPLOC4, PSMC1, UBQLN1, MAN1B1]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, MUM1, CIB1, BRCA1, PARK7, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, RFC1, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PAXIP1, PNKP, GPS1, COPS7B, COPS7A, XPC, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RNF138, RAD21, UBR5, ABL1, POLR2E, RAD54L, POLR2G, USP51, FANCI, POLQ, XRCC6, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, TTC5, UBE2T, POLE2, RFWD3, CDK2, ERCC5, MNAT1]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[TLR7]
GO:0007250;activation of NF-kappaB-inducing kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1337.9940718610228;6.8867018697843045;0.04478145746870162;0.8003065664753022;[ZFP91, TNFRSF10B, TNFRSF10A]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[RFC5, AQR, RFC3, RFC4, PCNA, RFC1, CCNH, GPS1, COPS7B, COPS7A, GTF2H4, DDB1, COPS5, POLR2B, POLR2E, EP300, POLR2G, ERCC5, MNAT1]
GO:0060800;regulation of cell differentiation involved in embryonic placenta development;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;69.44287305328919;8.390779266560578;0.0023241904665653296;0.7522251544931926;[STK4, STK3]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[PDGFRB, SMG1, CD80, IMPAD1, KIT, ZFYVE21, PIK3C3, MET, VAV1, PIK3CG, HBEGF]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[PTGER4, MAP4K2, GPS1, GPS2]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, CD40, SPHK1, TRADD, ITGB2, CIB1, NLRC4, AGER, NFKB1, RELA, MTDH, RPS6KA4, RPS6KA5, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, MAP3K3, XBP1, CD40, BTG1, JUP, SPHK1, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, PDCL3, RRAS, SP1, TBXA2R, ABL1, CTSH, TEK, EPHA1]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[IFNAR2, PKD2, CCR2]
GO:0046856;phosphatidylinositol dephosphorylation;8.0;1.0;0.875;9.628524252492122;218.1540246804484;6.686031174322154;0.007301418880178951;0.7169239451870815;[SYNJ1, MTM1]
GO:0006049;UDP-N-acetylglucosamine catabolic process;8.0;1.0;0.875;9.628524252492122;835.9135842063864;9.777073627680469;0.027977275390003692;0.875;[MGAT1]
GO:0018394;peptidyl-lysine acetylation;9.0;0.6696747006330769;0.7310779754968275;8.884083777544626;313.638027190515;5.076593261888053;0.010497182514167671;0.6558578406789737;[POLE4, DR1, CREBBP, CRTC2, ESCO1, YEATS2, IRF4, BRPF3, POLE3, EP300, YEATS4, TAF5]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, ZBTB20, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, SARS, ZNF12, HCFC2, RUNX2, THAP1, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, CBX4, XRCC5, WFS1, BCL11A, NONO, CAV1, H3F3A, NFKB1, CNOT7, CDK5, QARS, YEATS2, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, RCOR3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, TCF25, SUV39H1, CHD8, OTUD7B, BRCA1, LDB2, PTPRK, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, HBZ, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, TRIM33, LIMS1]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ITGB1, MBNL1, ENDOG, ELL, UBE2B, ANGPT1, MIB1, RIC8A, FLCN, CCNB1, FUT8, RXRA, ALS2, SIN3A, MAFF, CCM2, SOX8, MGAT1, EIF4E2, ATP7A, APBA3, SOX6, SEC24C]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, ZNF175, CCNK, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, YEATS4, UBE3A, IKZF1, GPATCH3, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, PAXIP1, MAX, NOLC1, RLF, SUPT6H, BCL2L12, HSPH1, MED30, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CDKN1C, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, CHD8, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, WDR43, CKS1B, FLCN, NIPBL, ING2, LBH, SIN3A, NUP62, HRAS, TEAD2, ZNF485, SEC13, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, ZFP90, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MAPRE3, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, PLAGL2, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, TTC5, NFIC, CAMK4, MARS, PSMC1, ASXL2, TAF7, CAMK1, TAF4, MIXL1]
GO:0001946;lymphangiogenesis;3.0;1.0;0.6981203125901445;9.628524252492122;22.057452475282865;7.292166977892469;7.382430839292881E-4;0.5710420709600095;[BMPR2]
GO:0010897;negative regulation of triglyceride catabolic process;8.0;1.0;0.875;9.628524252492122;579.5158089960104;8.390779266560578;0.01939587259672899;0.8041048419030481;[PIK3CG]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[TMED2, PKD2, MIB1]
GO:0034620;cellular response to unfolded protein;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;123.17901887317109;6.8867018697843045;0.004122690907765296;0.6753065664753021;[RHBDD1, HSPA6, TM7SF3]
GO:0006171;cAMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;7.292166977892469;0.20510234751766956;0.8053507106995271;[ADORA2A]
GO:0010792;DNA double-strand break processing involved in repair via single-strand annealing;8.0;1.0;0.875;9.628524252492122;150.42842160730993;7.9853141584524145;0.005034703894406622;0.7833693374183408;[RNF138]
GO:0007141;male meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;6.641579411751319;0.004687875406744682;0.7146506799819907;[ING2, RAD51C]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, RTKN, ROCK2, ARHGAP1, PARK7, RASGRP2, RAB21, RAB43, RAP1B, RHOT2, RHOT1, RAB20, RRAS, RAB40C, ARHGDIB, CFL1, RAB28, RAB6A, HRAS, RAB8B, USP8, KSR1, SETDB1, RAB27B, MYO9B, RHOC, RAB11A, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB35, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, KPNB1]
GO:0046621;negative regulation of organ growth;6.0;0.811012628672052;0.7286266269261705;9.360260265897443;146.9345464739773;6.599019797332524;0.0049177670379774545;0.6605944919115335;[WWC3, JARID2, STK4, STK3]
GO:0008354;germ cell migration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.540081573954176;7.57984905034425;0.0013568400465755524;0.6778748447945537;[ITGB1, KIT]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[RHOT2, RHOT1, COL1A2, RTKN, ROCK2, ARHGDIB, CFL1, ARHGAP1, TAX1BP3, ARHGEF1, MYO9B, RHOC]
GO:0042147;retrograde transport, endosome to Golgi;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;84.48667651462847;5.311165509025885;0.0028276930298722367;0.5947335637161829;[TMEM87A, VPS29, GOSR1, VPS52, STX5, VPS54, ZFYVE21, VPS26B, TBC1D23, RAB6A, PLEKHJ1, BAIAP3]
GO:0043116;negative regulation of vascular permeability;6.0;1.0;0.8231203125901445;9.628524252492122;22.58320658440663;7.379178354882098;7.558396008136816E-4;0.7004918368257019;[ANGPT1, ADORA2A]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR7]
GO:0045540;regulation of cholesterol biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;116.98845768213258;6.039404009397101;0.0039154983958446;0.705096027081865;[SQLE, GPAM, GGPS1, SP1, NFYC, SCAP, ELOVL6, ERLIN2, KPNB1, ACACA]
GO:0052066;entry of symbiont into host cell by promotion of host phagocytosis;11.0;1.0;0.9324289523296623;9.628524252492122;620.4476893303612;9.777073627680469;0.020765825795219024;0.9324289523296623;[ITGAV]
GO:0031584;activation of phospholipase D activity;8.0;1.0;0.875;9.628524252492122;67.57805180902054;7.9853141584524145;0.0022617765777498177;0.7833693374183408;[ARF4, CCL5]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[RNF138, ZFAND2A, CAV1, UBQLN1, RAD23A, TRIB3, SIRT2, RNF166]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, SYS1, RPL3, NUP107, RTKN, NCF1, BUB1B, ZDHHC6, ABCA12, IPO4, RPS15, IPO8, IPO9, LAMP2, LONP2, GSTK1, RPS9, RPS7, COG3, PAQR3, TOMM34, ARMCX3, NUP93, RAB35, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, SEH1L, AGER, FBLN5, NCKIPSD, UGT8, BAG4, RAD21, SSR1, RAB6A, FAM83D, S100A10, BBS2, TOR1A, PMM1, JUP, XRCC5, CAV1, RCC2, RAB3IP, PMM2, IFT122, NUP153, TIMM44, UBAC2, CDK5, GOLGB1, DCP1A, CD24, EZH2, ARF4, TRAM1, PIGU, ITGB2, SRP54, WASL, PTPRK, TRAM2, GPHN, NIPBL, SIN3A, NUP62, TMEM107, TMED2, TNPO1, TNPO2, ARL5A, RAB8B, GRIPAP1, SEC13, FCER1G, SSR2, SEPT2, GAK, ACOX2, RER1, AGPS, EXOC3, PIK3C3, MAPRE3, MAPRE1, VAMP5, EXOC1, MCPH1, BECN1, TOMM40, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, RGPD1, TM9SF4, AP3M1, WRN, RAB40C, PES1, LMNA, HEATR3, BID, RAE1, RPL19, PEX16, TIMM8B, UBL4A, SEPT11, TMEM30A, PEX19, ANGPT1, AGK, RPL23A, RAB11A, TM9SF1, SPCS2, SLMAP, VPS41, TSPAN17, RAB13, TAOK2, RAB3GAP2, RAB3GAP1]
GO:0033523;histone H2B ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.587702257971866;343.5530125033966;7.474488534686424;0.011498410150850943;0.8146746435927894;[RNF20, DTX3L, RNF40]
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.523163736834295;3784.4609618058316;6.343086423195323;0.1266625025978984;0.7568146869955557;[CLEC16A, PBK, PARK7, MTM1]
GO:0070507;regulation of microtubule cytoskeleton organization;7.0;0.6073376606709605;0.6545881955926808;8.242229891372231;33.71079736555127;4.584116776790259;0.0011282700500770656;0.5853513104054853;[ROCK2, VPS4B, CCNF, ARL2, CIB1, BRCA1, SENP6, TPR, NUP62, CEP70, ABL1, RAE1, CLASP1, MARK2, PDCD6IP, EML2, NSFL1C, CYLD, STAG1, STAG2, FES, CENPJ, CHMP4B, MAPRE3, MAPRE1, FKBP4, MET, PAFAH1B1, MCPH1]
GO:0009893;positive regulation of metabolic process;4.0;0.32290947553958305;0.4114547377697915;4.7056278727038725;22.547567684186998;1.6729745715368876;7.546467988962584E-4;0.33555599738967024;[CYFIP2, ZNF175, TFRC, MAML1, GPATCH3, ELK1, MYC, ZXDC, IER5, IER2, ENDOG, CSNK2A1, SECISBP2, PRKAB1, MED6, RFX4, HOXB4, JTB, PSME2, CDCA2, NOLC1, ZC3HAV1, MTDH, C3, HSPH1, RAD21, VPS11, HOXC4, NCKAP1L, ZNF143, CREBBP, PRELID1, JUP, EDEM1, PBX3, EIF2AK3, CDC7, ERLIN2, FLI1, SETX, EHD4, ARL2BP, EZH2, CDKN1C, ARF4, BTG2, CDKN1A, WDR48, SETD3, ELL, HOXC13, WDR43, BBC3, NIPBL, ING2, JARID2, TEAD2, HAVCR2, ZNF485, UPF1, DUSP5, ELOVL5, SPHK1, FCRL3, ATPIF1, TMEM173, SIRT2, GNL3, DDB1, NCOR2, NCOR1, PIGA, MTF2, RNF166, HBEGF, ZNF350, GPS2, TANK, UNG, BCLAF1, WRN, GGA3, RNF138, PPP1R7, STX5, PLAGL2, CCL19, BID, SF3B1, ZNF462, EGLN2, YTHDF3, CCL20, ATAD2, GPR55, CENPE, NFIA, NFIB, NFIC, PSMC1, TAOK2, MIXL1, LIMS1, NCF1, PDCD6, RORA, YEATS4, PARK7, YY1, FNTB, NEK1, ZNF564, RPS9, FBXO18, RPS7, PIAS2, RNF40, ARMCX3, OLFM1, ACLY, ILF3, MADD, ADNP, MAX, RLF, RAP1B, BCL2L12, BAG4, MED30, UBR5, ABL1, DVL3, MBP, FANCI, ZBTB17, DR1, WFS1, GLMN, TNFRSF10B, TNFRSF10A, NFKB1, CDK9, TFCP2, COPS5, CNOT7, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, CNOT8, MNAT1, NFE2L1, BCAR3, CIITA, BMPR2, ONECUT2, CALCOCO2, ITGB3, TRADD, ITGB2, PTPN22, PIK3CG, PTBP1, LBH, SIN3A, ITGAV, ATP7A, RFC5, RFC3, RFC4, KSR1, PEG3, DTX3L, RFC1, ITGA2, ZFP91, ARNT, RAD23A, ZFP90, DUSP22, TFDP1, TFDP2, POLR1E, LCP2, MET, BECN1, MTPN, HDAC3, HDAC1, WBP2, ROCK2, CEBPG, ITLN1, NLRC4, LRP8, CLEC3B, FZR1, KCTD20, U2AF2, TP53INP2, CCL5, TP53INP1, UBQLN1, POLR2E, POLR2G, CSK, ZNF622, E2F7, E2F8, TBX1, RNF20, ANGPT1, SEMA4D, P2RX7, RAD51, P2RX4, ASXL2, TRIM32, CD244, CCNK, CCNH, GFI1, EIF4A3, IKZF1, IKZF2, UBE2L3, RPS6KA4, RPS6KA5, DPF2, TRIM24, ARL6IP5, SOX8, IL12A, SKP2, SOX6, EPHB4, FLT3LG, MAPK8IP3, RUNX2, SFRP1, TWSG1, KARS, SOAT1, IL23A, MTCP1, TRIB3, EPHA1, PAXIP1, EBI3, FXR1, HLTF, SCAP, ZBED1, NTSR1, XBP1, XRCC6, SETDB1, XRCC5, EAF2, PILRB, CCDC88A, STAG1, CALM3, CALM1, CD24, CALM2, CD40, ZFAND2A, KIF14, IL27, BRCA1, AATF, AKAP13, NNT, C1QBP, TMED2, CTSH, HRAS, CCR2, MAP4K2, SEC13, NCOA6, COMMD1, PPRC1, GFRA2, VAV2, GAL, TFEC, KIT, MAPRE3, TLR7, ARHGEF5, PCNA, HEATR1, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, SERTAD2, PERP, LMNA, GPBP1L1, EXOSC3, MAP3K3, MAP3K1, RYK, NFYC, GRHL1, ITCH, NLRP12, TTC5, CAMK4, MARS, RAB3GAP2, CAMK1, RAB3GAP1, SCARB1, CRTC2, CD80, ARID4A, CIB1, UBE3A, COMT, IGF1R, EP300, PDGFRB, ERN1, BRMS1, TBL1XR1, CCNE1, TIMELESS, CARD11, DIABLO, CLEC16A, STK4, SUPT6H, AGER, ACACA, STK3, CCNB1, NLRP2, NLRP3, RIPK1, CYTL1, ECT2, MARK2, BPTF, TFAP2A, PRNP, UBE2I, UBE2B, RHBDD1, CAV1, NFKBIA, IL6, PHF19, CHD8, DDX41, LDB2, PKD2, CKS1B, RBM3, FLCN, CASP3, NUP62, DACT1, FGA, TBP, KLF13, RBM15, FGG, MKL1, PLAUR, PPP2R5D, OXSR1, SENP2, SAFB, ARID1A, MASTL, CREB3, RBL1, ALS2, ELF4, IRF4, EAPP, VAC14, STOML2, POLDIP3, PNKP, THBS1, TAF1A, MTA2, CHURC1, PDE6H, EYA2, ARID3B, DEK, HSPE1, USF2, TSHR, CD4, CCS, TNIP2, TAF7, CDK2AP1, PTX3, KRAS, FAM98A, TEK, TAF4]
GO:0006383;transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.499312521012115;583.8786478812184;6.113511981550823;0.01954189288791682;0.7278862989048107;[GTF3C1, ZNF143, TBP, ELL, POLR3B, POLR3C, POLR3E, POLR2E]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[HSD3B7, STARD3, SCARB1, GGPS1, ERLIN2, ACLY, SQLE, EBP, NSDHL, RXRA, SOAT1, SNX17, FDXR, SCAP, APOL1, SCARF1, NFE2L1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, CD40, UBE2I, SLC20A1, TRADD, ZDHHC13, TNFRSF10B, RHOC, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TRIM32, CARD11, TMED4]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ITGB1, NCKAP1, TOP2B, C12orf57, RYK, WASL, TRAK1, UGT8, WEE1, LRFN4, SLC9A6, ALS2, CDK5, ADORA2A, NFIB, TAOK2, NCKAP1L, NPTX1, ATP7A, NEFH, PAFAH1B1, ZNF365]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[FCER1G, MAP3K1, LCP2, CALM1, NFKB1, VAV1, RELA, CARD11, VAV2]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA6B, SEMA4D, FOXG1, GFI1, PAQR3, CIB1, THOC2, MIB1, GAK, EIF4ENIF1, CDK5, RUFY3, SOX8, LRIG2, FKBP4, PAFAH1B1, ZNF365]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, CD40, DIABLO, PDCD6, TRADD, CIB1, BRCA1, KRCC1, BBC3, POLB, TFPT, SGPL1, ZMAT1, BAG3, PERP, CASP3, MKNK2, DPF2, ARL6IP5, TP53BP2, ABL1, CASP2, EP300, RIPK1, IL12A, ITGAV, ZNF622, BID, HRAS, APPL1, XBP1, SIVA1, EYA2, PARP2, CD70, CAV1, G0S2, TNFRSF10B, TNFRSF10A, ERN1, P2RX7, P2RX4, BCL3, DDIT4, TRIB3, CD24]
GO:0008202;steroid metabolic process;4.0;0.566269677792466;0.5331348388962329;7.508260716292031;35.315100643705854;4.247644540169047;0.001181964637017687;0.4672247393199168;[SCARB1, HSD17B4, COMT, HSD17B8, GBA2, SULT1A1, SGPL1, EBP, NSDHL, RXRA, FDXR, SCAP, APOL1, SCARF1, SULT1A3, HSD3B7, STARD3, GGPS1, OSBPL2, UGT2B17, ERLIN2, ACLY, SQLE, ACOX2, SOAT1, SNX17, SLC27A2, NFE2L1, UGT2B7]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FXR1, UPF1, XRN1, YTHDF3, FASTKD1, YWHAB, DCP1A, TNPO1, EXOSC3, YWHAZ, DCP2, PUM2]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[BTG1, FLT3LG, HIF1AN]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP2, NCKAP1, ACTR2, WIPF2, ARPC1A, WASL, VAV1, VAV2, NCKIPSD, ARPC2, ELMO1, ABL1, NCKAP1L]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, DOCK8, CD80, SIRPG, CIB1, FLCN, C1QBP, CTLA4, IL12A, ITGAV, CCR2, HLA-DPA1, HAVCR2, FGA, IL4R, ITGA2, FGG, PDCD1LG2, UNC13D, VAV1, ITPKB, SFRP1, IL23A, EPHA1, CARD11, EBI3, ARL2, CORO1A, AGER, FBLN2, BAG4, HLA-DMB, HSPH1, CCL5, ABL1, NLRP3, NCKAP1L, CSK, CCL19, IL12RB1, S100A10, XBP1, ANGPT1, JUP, PLEKHA2, CAV1, CYLD, CD4, IL6, CDK6, ARPC2, GPAM, HLA-DPB1, PDCD1, TEK, CD24, LIMS1]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BAG3, EYA2, CASP3, MKNK2, CASP2, ITGAV, APPL1]
GO:1901800;positive regulation of proteasomal protein catabolic process;10.0;0.7763722522362496;0.8034271379790452;9.430698509162202;1662.1011242697743;5.104244793218563;0.05562902883541267;0.6762723279577749;[XBP1, RNF138, ZFAND2A, EDEM1, PSMC1, CAV1, UBQLN1, RAD23A, TRIB3, SIRT2, RNF40, RNF166]
GO:0043369;CD4-positive or CD8-positive, alpha-beta T cell lineage commitment;5.0;0.7980440201809971;0.6892630219514189;9.022388448921806;21.33815949828185;7.212124270218933;7.141689953107157E-4;0.659069382437994;[CYLD, IL6, IRF4]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, BMPR2, RUNX2]
GO:0048814;regulation of dendrite morphogenesis;10.0;0.8259837884571596;0.8282329060895002;9.533214072687796;153.5143611256957;5.334422371190153;0.0051379875129217364;0.6880436199995941;[RAB21, FXR1, ACTR2, CDK5, SEMA4D, CAPRIN1, CFL1, LRP8, PAFAH1B1]
GO:0048813;dendrite morphogenesis;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;64.60914726719044;6.063501560976162;0.0021624100145753813;0.6850877518099798;[ITGB1, CDK5, TAOK2, TRAK1, ZNF365]
GO:0046636;negative regulation of alpha-beta T cell activation;9.0;0.7090535922965819;0.75076742132858;9.267510906954792;268.68230308327577;6.221725566191056;0.008992554885823345;0.7144199599751273;[ITCH, TWSG1, IL4R, ADORA2A, RC3H2]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[SFRP1, TWSG1, CDK6, IGFBP5, SEMA4D]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[VPS18, RABGAP1, TBC1D8, TBC1D2B, CORO1A, TRIM9, VPS41, VPS11, RUNDC1, EVI5L, TBC1D22A, TBC1D15, VPS16]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB1, FCER1G, ITGB4, ITGB3, ITGA2, RCC2, ITGB2, NEDD9, ITGAE, VAV1, FUT8, ABL1, CCM2, ITGAV]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, BAG3, PDCD6, TPR, TFEC, HSPA6, RBBP7, SLU7, IER5, THBS1, EIF2S1]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[ITGB1, PTRH2, CAV1]
GO:0035815;positive regulation of renal sodium excretion;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.61946749691032;7.069023426578259;0.004539061527524972;0.7365101867784198;[ADORA2A]
GO:0060706;cell differentiation involved in embryonic placenta development;4.0;0.8259837884571596;0.6629918942285797;9.089527751759436;40.68519770516384;6.641579411751319;0.0013616969528911006;0.5896506799819907;[SENP2, STK4, E2F7, E2F8, STK3]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[ITGB1, CXCL6, CIITA, CDKN1A, CD40, CD80, TRADD, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, RPS6KA5, MYC, CASP3, CFL1, IL12A, CCR2, HLA-DPA1, IFNAR2, IL4R, FLT3LG, HLA-A, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, KIT, PSME2, LCP1, HLA-DQB1, EBI3, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, BAG4, CCL5, IL21R, NCAM1, RIPK1, CCL19, IL12RB1, HLA-DQA1, CCR10, BBS2, MAP3K3, CCL20, CD70, TNFRSF10B, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, HLA-DRB3, LIMS1]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[NFKBIA, GPS2, ABCA12]
GO:0035810;positive regulation of urine volume;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;23.90496242438734;7.138016298065211;8.000775792748091E-4;0.6552794972956795;[ADORA2A]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[POLQ, FEN1, WDR48, FBXO18, GINS4, NSMCE2, CDC7, BRCA1, YY1, RAD51AP1, NIPBL, WRN, RAD51C, RAD51, RNF138, RFWD3, RAD54L]
GO:0043254;regulation of protein complex assembly;5.0;0.5023590972498763;0.5414205604858584;6.876988939450173;27.318252308649967;3.6656062881777913;9.14317319939619E-4;0.4777002879064576;[HRK, NCKAP1, GMFB, WIPF2, ARPC1A, KIF14, WASL, PARK7, SENP6, TRIM9, EP300, ARFIP1, DACT1, VPS18, ACTR2, TFIP11, RHOC, SPTB, EML2, SIRT2, DDB1, VDAC2, LCP1, MAPRE1, FKBP4, ANKRA2, MET, ARHGEF5, PTGER4, MTPN, PAXIP1, ARL2, IQGAP2, CORO1A, ATXN2, BCLAF1, BAG4, NCLN, VPS11, ABL1, NCKAP1L, BID, CLASP1, VPS16, VASP, DR1, H3F3A, GTF2H4, SETX, VIL1, CNOT6, PAN3, ARPC2, CNOT1, FES, PSMC1, VPS41, TAF7, ERCC5]
GO:0006275;regulation of DNA replication;7.0;0.6144040707577935;0.6581214006360973;8.623002386890024;150.73814970462044;5.142344639450834;0.005045070215086414;0.6138991092621975;[ANKRD17, USP37, STOML2, PCNA, GMNN, PPP2CA, HRAS, E2F7, ZNF365, E2F8, RFC5, TIPIN, RFC3, RFC4, FBXO18, ESCO1, WDR18, DONSON, WRNIP1, CDC7, SENP2, CCDC88A, STAG2, MSH3, CDK2, TIMELESS]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[VPS18, DTX3L, MGRN1, VPS33A, VPS4B, VPS41, CLEC16A, VPS11, TRAK1, LYST, VPS16, MTM1]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[AHCYL1, CCNH, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, ALKBH5, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, AQR, MBNL1, RBM15, BUD31, SSU72, PAPD4, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, PRPF3, FASTKD5, SNRPG, CD2BP2, SLU7, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, SUPT6H, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, SMNDC1, DCPS, SF3B1, SPEN, CPSF6, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CWC15, LSM5, GTF2H4, PAN3, SON, ACIN1, MNAT1, GRSF1]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[ROCK2, TRADD, TANK, NFKB1, RELA, NFKBIA, IRAK1BP1, NKIRAS1, TNIP2, TIFA, BCL3, SNIP1, RIPK1, TLR7, CARD11]
GO:1902902;negative regulation of autophagosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;476.81513928252696;7.292166977892469;0.015958573606020727;0.769162383550154;[BECN1, CHMP4B, MTM1]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[ERRFI1, CCNK, GMFB, NCF1, CCNH, CD80, CCNF, CIB1, PARK7, IGF1R, RPS6KA4, RPS6KA5, MYC, ARL6IP5, NEK1, IL12A, EPHB4, PDGFRB, FBXO18, PAQR3, FLT3LG, VRK2, MAPK8IP3, CDC25A, ERN1, SFRP1, TWSG1, KARS, CCNE2, IL23A, CCNE1, DDIT4, MADD, JTB, MTCP1, TRIB3, ADNP, EPHA1, PKMYT1, STK4, AGER, STK3, IL22RA2, C3, RAP1B, CCNB1, BAG4, HSPH1, RRAS, PRDX1, STK38, ABL1, DVL3, NCKAP1L, RIPK1, ECT2, FAM83D, MARK2, PRNP, XRCC6, UBE2B, AMBP, XRCC5, CAV1, EIF2AK3, TNFRSF10B, TNFRSF10A, PILRB, CDK9, CCDC88A, IL6, COPS5, CDK6, CNOT7, EHD4, CDK5, ARL2BP, QARS, GNAQ, PKIA, FGFR1OP, CALM3, CRIPAK, CALM1, MNAT1, CD24, CALM2, CCNJL, EZH2, CDKN1C, BCAR3, CDKN1A, CD40, BMPR2, ITGB3, ITGB2, KIF14, PTPN22, PKD2, PIK3CG, DUSP14, CKS1B, FLCN, AKAP13, NNT, CASP3, NUP62, PBK, ITGAV, HRAS, DACT1, HAVCR2, FGA, DUSP5, MAP4K2, KSR1, SPHK1, FCRL3, FGG, PLAUR, ZFP91, PPP2R5D, OXSR1, SENP2, GFRA2, SIRT2, ITPKB, DUSP22, NCOR1, ALS2, ADORA2A, CTDSP2, KIT, LCP2, MAPRE3, TLR7, CHMP6, MET, ARHGEF5, PAFAH1B1, HBEGF, HDAC3, ROCK2, GPS1, ITLN1, GPS2, LRP8, THBS1, PPP2CA, SNX25, CCL5, CSK, ZNF622, CCL19, TBX1, MAP3K3, CDKN2C, MAP3K1, PDE6H, ANGPT1, SEMA4D, CCL20, RYK, GPR55, P2RX7, CENPE, PDCL3, ITCH, CD4, NLRP12, TAOK2, TAF7, CDK2AP1, KRAS, SPRY1, CAMK1, TEK]
GO:0018242;protein O-linked glycosylation via serine;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;336.6244338764004;7.9853141584524145;0.011266516859521314;0.8046099625986299;[GALNT1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, FCER1G, CCL20, CCL5, ITGB2, NCKAP1L, CCL19, VAV1, PIK3CG]
GO:0018243;protein O-linked glycosylation via threonine;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;335.8824965316705;7.8311634786251565;0.011241684884293463;0.7967266896635242;[GALNT11, GALNT1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[ITGB1, CXCL6, GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, PIK3CG, CCL5, NCKAP1L, ITGAV, CCL19, CCR2, HSD3B7, FCER1G, ANGPT1, CCL20, CAV1, TNFRSF10B, TNFRSF10A, ATP1B2, VAV1, NLRP12, IL6, COL1A2, KIT, SDC1, TEK, CD244, ARHGEF5]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[NFKBIA, IL6, ITGB3, ITGAV]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[PDCL3, BMPR2, SP1, ITGB3, PDCD6, ARNT, TEK]
GO:0033624;negative regulation of integrin activation;7.0;1.0;0.8509193652572005;9.628524252492122;113.99365377889563;9.083926447120524;0.0038152650043517884;0.8154717862087246;[PTGER4, KIF14]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[BAG4, THBS1]
GO:0055118;negative regulation of cardiac muscle contraction;9.0;0.811012628672052;0.801746939516315;9.466005322994347;171.6071423008873;7.9853141584524145;0.005743536616409487;0.8046099625986299;[PIK3CG]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PRNP, CDKN1A, CDKN2C, PKD2, THBS1, PRKAB1, PPM1G, ERN1, CDK6, FAP, RHEB, MYC, TP53INP1, ABL1, IL12A, PRR11, HRAS, EIF4G2, MCPH1]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, AQR, MBNL1, RBM15, BUD31, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7, SF3B5, SF3B2, WBP4, DDX23, SUPT6H, PPP2CA, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, SMNDC1, DCPS, SF3B1, SPEN, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CWC15, LSM5, SON, ACIN1]
GO:1905461;positive regulation of vascular associated smooth muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.5070754231924;7.9853141584524145;0.005003867266781941;0.8236103492792612;[STK4]
GO:1903169;regulation of calcium ion transmembrane transport;8.0;0.6260725219892441;0.688036260994622;8.50005900067433;58.212370637888874;4.835431205071165;0.001948315657517866;0.6222841766978864;[PRNP, AHNAK, PKD2, CORO1A, CRHR1, PIK3CG, NPPA, UBQLN1, ABL1, CALM3, CALM1, CALM2, NTSR1, ATG5]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[VIL1, ARF4, DGKD, RPS6KA5, CAMLG, FES, ABL1, FAM83A, HBEGF]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, TWSG1, FUT8, COL1A2, BMPR2, PTPRK]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, XBP1, ASXL2, STK4, STK3]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[HBZ, RRM1, SEPT11, XRCC6, CPSF6, JUP, YWHAB, TRADD, IKZF1, HSD17B8, PRKAB1, GCHFR, BAG4, COL1A2, NUP62, RIPK1, HRAS, S100A10]
GO:0043666;regulation of phosphoprotein phosphatase activity;9.0;0.7436939687323844;0.7680876095464813;9.328419660041783;158.30216566976694;5.058574756385375;0.005298231022267458;0.6549363734696205;[PDGFRB, PPP1R11, ROCK2, FCRL3, PPP2R5D, PPP2R2A, MASTL, HSP90B1, NSFL1C, NUAK1, PPME1, PPP1R7, RCAN3, PHACTR2, NCKAP1L, CALM3, CALM1, CALM2]
GO:0045603;positive regulation of endothelial cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.503361109538115;205.17606198895368;7.004484905440688;0.006867058148302753;0.7091290490632969;[BTG1]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[KIT, PIK3CG]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ITGB1, ERRFI1, CD40, DOCK8, ARHGAP1, DOCK11, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, SEC13, TBC1D8, TBC1D2B, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, DEPDC1, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RABGAP1, RASGRP2, RIC8A, ABR, ARHGAP21, CCL5, DVL3, NCKAP1L, CCL19, ECT2, A2M, TBC1D15, S100A10, STARD13, SEMA4D, CCL20, RCC2, MYO9B, ARHGAP25, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1]
GO:0035635;entry of bacterium into host cell;7.0;1.0;0.8509193652572005;9.628524252492122;28.374411874040543;7.697632086000634;9.496660301113433E-4;0.7445766281117727;[MET, CBLL1]
GO:0034421;post-translational protein acetylation;9.0;1.0;0.896240625180289;9.628524252492122;308.12661660850654;8.67846133901236;0.010312720561935343;0.8400575416471059;[ESCO1]
GO:0032007;negative regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;5.926926025970411;0.008015432820232688;0.6781032725983739;[FLCN, PDCD6, DDIT4, ARNTL, MTM1]
GO:0032008;positive regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;6.250713103064308;0.008002824611389124;0.6946617587785947;[FLCN, SEC13, HDAC3, SEH1L, RHEB, CLEC16A]
GO:0032369;negative regulation of lipid transport;6.0;0.6281612110245125;0.6372009181024008;8.242229891372231;82.88956312991112;6.558197802812269;0.0027742390821944756;0.6585068532133508;[ITGB3, ITGAV, THBS1, NFKB1]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[ABL1, SOX8, ITGAV]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[NIPBL, STAG2, RAD51C, ESCO1, RAD21, BUB1B]
GO:0032480;negative regulation of type I interferon production;6.0;0.7980440201809971;0.722142322680643;9.186691500213083;65.25422870398782;6.015873511986907;0.002184000309729388;0.6307723637598831;[YY1, CYLD, ITCH, NPLOC4, GPATCH3, HAVCR2]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNB1, CCNK, CCNH, MAPRE3, MNAT1, PKD2, CKS1B]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, RHOC, VAV1, VAV2, SFRP1, GAL, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, PTGER4, SUCNR1, ROCK2, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, CALM1, CALM2]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[CMTM7, ITGB1, DOCK11, DCLRE1C, SP3, BCL3, CEBPG, KIT, ABL1, EP300, GPS2, CARD11]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, PIGT, RYK, ROM1, PAPD4, RORA, RUNX2, PPP1CC, SFRP1, HERC1, CDK5, CASP3, DDIT4, SOX8, ATP7A, IER2, PAFAH1B1]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB3B, RAB27B, RAB11A, RAB21, RAB43, RAB20, RAB40C, RAB13, RAB35, RAB18, RAB28, RAB6A, RAB8B]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, ITGAV, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, ALDOC, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, AP1M1, XRCC6, TMEM30A, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[PTGER4, AKAP13, GNG2, ADORA2A, TBXA2R, GNAQ, CRHR1, TSHR]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[ERRFI1, BTG2, OXTR, BTG1, MAX, ABCB4, CRHR1, RELA, RAP1B, PPAT, NPPA, SCAP, CSK, CYC1, RAB8B, EIF2B4, XBP1, ABCC2, IGFBP5, CAV1, CAD, TSHR, NFKB1, RNF40, GAL, SP1, MARS, RAB13, TRIB3, TEK]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, CD40, BAG4, KARS, CD70, TRADD, TNFRSF10B, RIPK1, TNFRSF10A, RELA, LIMS1]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[BAG4]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[TBX1, SEMA6B, SEMA4D, CFL1, SOX8]
GO:0001514;selenocysteine incorporation;9.0;1.0;0.896240625180289;9.628524252492122;323.86608553742207;7.697632086000634;0.010839506422383753;0.7898978880348613;[SECISBP2]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[EP300, MIB1]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[ITGB2, ITGAV, MIXL1]
GO:0035747;natural killer cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;8.67846133901236;0.003205147533980157;0.8188169164668168;[PIK3CG]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, COPA, GMFB, NCF1, EBI3, IL27, PARK7, AGER, CCL5, NPPA, IL12A, FAM3C, CCL19, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, KLHL24, IL6, GAL, CDK5, IL23A, PNOC, SCGB3A1, CHMP6, KCNK3, HBEGF]
GO:1904380;endoplasmic reticulum mannose trimming;10.0;0.8436909121759173;0.837086467948879;9.446202695698167;249.61615283182627;7.004484905440688;0.008354427995328538;0.7734506956670166;[RNF103, EDEM1, SYVN1, DERL2, MAN1B1, MARCH6]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ITGB1, VPS18, SCARB1, GYPA, TFRC, SIVA1, ITGB3, ITGA2, CD80, NUP153, VAMP8, ITCH, CLDN9, NCAM1, ITGAV, XPR1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, SEMA4D, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, WASL, RHOC, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, KIT, ALDOA, CSNK1G2, CSNK1G1]
GO:0007271;synaptic transmission, cholinergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.409777797693995;8.61437622431563E-4;0.7027963346592216;[ADORA2A]
GO:0046716;muscle cell cellular homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.94563669038233;6.781341354126479;0.0010691917108206317;0.6370391240755715;[LAMP2, ALDOA, TRIM32, MTM1]
GO:0007032;endosome organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;5.528578385631111;7.000311565738116E-4;0.5729727676072827;[VPS18, ARFGEF2, USP8, PDCD6IP, VTA1, VPS4B, VPS33B, VPS37A, VPS37B, RAB11A, ALS2, VPS11, CHMP4B, PIK3C3, CHMP6, PLEKHJ1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[RABGAP1, RCC2, TBC1D8, RUNDC1, TAX1BP3, TBC1D2B, EVI5L, ECT2, EPHA1, TBC1D22A, TBC1D15]
GO:0032230;positive regulation of synaptic transmission, GABAergic;8.0;1.0;0.875;9.628524252492122;135.4246808583232;7.212124270218933;0.0045325421940280546;0.7438283705770736;[OXTR, ADORA2A]
GO:0006065;UDP-glucuronate biosynthetic process;8.0;1.0;0.875;9.628524252492122;847.4108547704801;8.67846133901236;0.028362078688912176;0.8188169164668168;[UGDH, UGP2, SLC35D1]
GO:0006068;ethanol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;292.83912655610527;7.292166977892469;0.009801062027729285;0.7238411236270654;[SULT1A1, SULT1A3]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, MSLN, PSMD8, PSMD7, PSMD4, PSMD2, SKP2, FGA, IGFBP5, ESCO1, FGG, COMMD1, RABGGTA, DDB1, PSMA1, PSME2, ITIH2, GPS1, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, ASB8, RAB13, STT3A, CALU, FBXL3, ASB3, KBTBD8]
GO:0001963;synaptic transmission, dopaminergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;7.069023426578259;8.61437622431563E-4;0.7365101867784198;[CDK5, ADORA2A]
GO:1990108;protein linear deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;8.67846133901236;0.006860975150996652;0.8590579283277371;[CYLD]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[BECN1, AHCTF1, KIF14, KIF23, RAB11A, CIT, FLCN, SPAST, KIF3B, NUP62, PKP4, PIK3C3, CALM3, BIRC6, KIF20A, CALM1, ECT2, CALM2, E2F7, E2F8]
GO:0030166;proteoglycan biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.500690880982237;394.05247571105167;6.311337724880743;0.013188581737844911;0.6736814700148209;[EXTL2, BMPR2, CYTL1]
GO:1904271;L-proline import across plasma membrane;13.0;1.0;0.9625549647676366;9.628524252492122;1268.6576794063567;9.777073627680469;0.04246083081194589;0.9625549647676366;[SLC36A4]
GO:1903076;regulation of protein localization to plasma membrane;7.0;0.7307253602413294;0.7162820453778652;9.117698628726131;62.75471671371763;5.346256828837156;0.0021003438928297916;0.6243271881103005;[VIL1, VAMP8, ITGB1, PRNP, CDK5, RER1, PPFIA1, CIB1, CSK, RAB11A, APPL1]
GO:0010693;negative regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.7238800504293;8.67846133901236;0.010566994132243301;0.8590579283277371;[SEMA4D]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, UBR5, SYVN1, UBE3A, RFFL, MARCH6, TRIM32]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[ING2, SPAG6, STRBP, H3F3A, KIT, CIB1, AFF4, IQCG]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[CD80, PTPN22, THBS1, CASP3, ARHGDIB, ABL1, CTLA4, MBP, HAVCR2, PRNP, LAG3, IL4R, ANGPT1, SEMA4D, SWAP70, RCC2, FGG, GLMN, PDCD1LG2, RC3H2, DUSP22, CYLD, ITCH, TWSG1, ADORA2A, CD9, FXYD5, CBLL1]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[VIL1, ITGB1, PRNP, RER1, CIB1, RAB11A]
GO:0009229;thiamine diphosphate biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;781.808534724552;9.777073627680469;0.026166428075229915;0.8231203125901445;[TPK1]
GO:2000628;regulation of miRNA metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;73.2852406259017;7.57984905034425;0.002452791051314361;0.738553198190834;[HRAS, NFKB1, RELA, RC3H2]
GO:0001973;adenosine receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.8657018871206;7.57984905034425;0.0018363056662359847;0.7626338329336335;[ADORA2A, ADORA3]
GO:0001975;response to amphetamine;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;70.50276562849314;6.558197802812269;0.0023596641172160164;0.6585068532133508;[OXTR, ADORA2A]
GO:0019255;glucose 1-phosphate metabolic process;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;72.82688802824934;9.083926447120524;0.0024374504023614934;0.7547934328124444;[UGP2, PGM3]
GO:0031000;response to caffeine;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;108.60320465904744;7.069023426578259;0.003634851523399718;0.6846304993685643;[ADORA2A, CAD]
GO:2000623;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;1.0;0.9152410118609203;9.628524252492122;1197.4866120488684;8.390779266560578;0.04007879923729291;0.8443458537639685;[SECISBP2]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[CCDC88A, SPAST, KIF19, KATNAL1, TUBGCP2, VPS4B, CIB1, TUBG1, KPNB1, CLASP1, RAB11A, PAFAH1B1]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[ITGB1, NCKAP1, RTKN, WDR1, EPB41, ROCK2, WIPF2, ARPC1A, WASL, CORO1A, AQP1, ABR, CFL1, ABL1, NCKAP1L, PDGFRB, PDCD6IP, KIF23, RHOC, BCR, VIL1, NISCH, MKLN1, DIAPH3, PARVG, CDK5, RAB13, TAOK2, KIT, SPECC1L, ELMO1, KRAS, DOCK2, TRIM32, ARHGEF5, PAFAH1B1]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[CD40, CCNK, CCNH, CIB1, PKD2, STK4, THBS1, AGER, PIK3CG, STK3, CKS1B, PPP2CA, AKAP13, CCNB1, DVL3, RIPK1, CSK, CCL19, HRAS, PDGFRB, MAP3K3, DUSP5, MAP4K2, MAP3K1, PDE6H, MAPK8IP3, ERN1, P2RX7, KARS, ALS2, TAOK2, KIT, MADD, MTCP1, KRAS, CALM3, MAPRE3, CAMK1, CALM1, MNAT1, CD24, CALM2, ARHGEF5, EZH2]
GO:0032456;endocytic recycling;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.979792040619635;6.409777797693995;0.0016393095606485504;0.6509166472493662;[EHD4, RAB13, VPS52, RAB35]
GO:0033386;geranylgeranyl diphosphate biosynthetic process;8.0;1.0;0.875;9.628524252492122;561.3122105398157;9.777073627680469;0.018786614538575143;0.875;[GGPS1]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[SENP6, UBE2I, CBX4, BCL11A, SUMO3, NSMCE2, ZBED1, SENP2, PIAS2]
GO:0033384;geranyl diphosphate biosynthetic process;8.0;1.0;0.875;9.628524252492122;560.6190633592574;9.083926447120524;0.018763415526233822;0.839552420951524;[GGPS1]
GO:0034472;snRNA 3'-end processing;10.0;0.8259837884571596;0.8282329060895002;9.423729839846109;715.1711836533467;6.444869117505266;0.023936135904599073;0.7448319182472036;[INTS7, INTS6, EXOSC3, INTS8]
GO:0043069;negative regulation of programmed cell death;6.0;0.5470854108181258;0.5966630179992074;7.49501548954201;59.55619652718796;2.9592430562263194;0.001993292300667925;0.47445614010443393;[CIB1, PARK7, UBE2Z, TM7SF3, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, PPIF, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, BRCA1, AATF, PIK3CG, ING2, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, BIRC6, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, DCPS, TBX1, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0048633;positive regulation of skeletal muscle tissue growth;9.0;1.0;0.896240625180289;9.628524252492122;367.14841175535776;8.390779266560578;0.012288126929333416;0.8253454670833372;[MTM1]
GO:0061738;late endosomal microautophagy;5.0;1.0;0.7902410118609202;9.628524252492122;39.83166466328102;8.67846133901236;0.0013331299701091492;0.7340579283277371;[VPS4B]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[MAP3K1, TLR7]
GO:0071773;cellular response to BMP stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.280566066213989;0.003262744749111514;0.6443087532925187;[SFRP1, BMPR2, RUNX2]
GO:2000637;positive regulation of gene silencing by miRNA;9.0;0.8436909121759173;0.8180860812682478;9.434368238051164;125.11806367321617;6.7325511899570465;0.004187588992195782;0.740543606130341;[FXR1, PUM2]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[PTGER4, XBP1, IL4R, CADM1, GLMN, PTPN22, P2RX7, NLRP12, KARS, NLRP7, NLRP2, ABL1, NLRP3, MBP, CCL19, CD244, HAVCR2]
GO:0051923;sulfation;4.0;0.811012628672052;0.655506314336026;9.158520623246385;21.66117258152157;7.004484905440688;7.249799525138476E-4;0.6082096838060964;[SULT1A1, SULT1A3]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[PTGER4, GPI, PTPN22, TM7SF3, AACS, NLRP7, NLRP2, ABL1, NLRP3, MBP, CCL19, HAVCR2, FGA, XBP1, IL4R, CADM1, FGG, GLMN, BAIAP3, P2RX7, NLRP12, IL6, KARS, ADORA2A, CD244, PPID, EXOC1]
GO:0035435;phosphate ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;110.11210983553856;7.138016298065211;0.003685353221730381;0.7400384854347593;[SLC25A3, SLC37A1, ANKH, SLC20A1, SLC25A10, XPR1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, OXTR, RPS6KA4, RPS6KA5, RPS6KA2, MYC, ARL6IP5, GTSE1, PAQR3, BCR, NISCH, DEPDC1B, KARS, DDIT4, TRIB3, PAXIP1, CRHR1, ABR, NUAK1, RHOT2, RHOT1, RRAS, TP53BP2, STK38L, CCR10, SULT1A3, XBP1, SETDB1, EIF2AK3, RAB27B, SETX, CCDC88A, CYLD, COL1A2, CALM3, CALM1, RGL1, CD24, CALM2, BTG2, CDKN1A, CD40, ARHGAP1, BRCA1, BBC3, AKAP13, AKAP11, NKIRAS1, C1QBP, CTSH, HRAS, TEAD2, RAB8B, CCR2, DUSP5, MAP4K2, SPHK1, TMEM173, RHOC, GFRA2, SIRT2, VAV1, CIT, VAV2, ITPKB, GAL, KIT, DEPDC1, TAX1BP3, ARHGEF1, TLR7, ARHGEF5, EXOC1, HBEGF, PTGER4, PCNA, GPS1, GPS2, TANK, RELA, PPP2CA, PERP, BID, MAP3K3, MAP3K1, CCL20, MYO9B, RAB11A, ITCH, CAMK4, TAOK2, CAMK1, TJP2, RAB3B, DGKD, RTKN, DGKA, CD80, SIRPG, IL5RA, DEFB1, PARK7, IGF1R, RAB43, DOCK11, ARHGDIB, CFL1, EP300, SNIP1, NEK1, IFNAR2, PDGFRB, USP8, IGFBP5, ERN1, RAB35, ELMO1, KPNB1, CARD11, DIABLO, CLEC16A, ITPR2, RASGRP2, STK4, KRCC1, RASGRP4, STK3, RAP1B, CCNB1, ZMAT1, TBXA2R, STK38, ABL1, DVL3, MBP, RIPK1, ECT2, RAB6A, MARK2, PRNP, IFT122, TNFRSF10B, CNOT10, NFKB1, NFKBIA, CNOT4, CNOT6, IRAK1BP1, CNOT7, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, NMUR1, CNOT8, LSM14A, BCAR3, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, TRADD, ATP2A2, PKD2, PIK3CG, POLB, FLCN, CASP3, CASP2, ITGAV, KSR1, OXSR1, MASTL, SPTB, TFDP1, ALS2, TFDP2, ADORA2A, PIK3C3, LCP2, LCP1, DOCK2, MET, ROCK2, RAB21, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, TIFA, MKNK2, NCAM1, ZNF622, RAB28, SH2B3, E2F7, E2F8, ARFGEF2, ANGPT1, TSHR, SNRK, P2RX4, TNIP2, ASB8, RAB13, RAB18, CCM2, KRAS, TEK, ASB3]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, BAG4, ANGPT1, CAV1, MTCP1, CAMK1, PARK7, STK4, GFRA2]
GO:0050710;negative regulation of cytokine secretion;9.0;0.6954798709641801;0.743980560662379;9.089527751759436;549.9868642983072;5.734022359845919;0.01840756539202174;0.6894787953221185;[PTGER4, NLRP12, PPP1R11, ANGPT1, NLRP7, NLRP3, PTPN22]
GO:0010390;histone monoubiquitination;11.0;0.8933024483968273;0.8790801765280758;9.589303539338841;498.95626046972137;6.375876246018314;0.016699617006440744;0.7584915600596062;[DDB1, RNF20, DTX3L, RNF40]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNG1, KCNK6, SLC23A2, CLIC5, SLC25A3, COX4I1, SLC35B1, ARHGAP1, ATP2A2, PKD2L1, COX6A1, PKD2, BEST3, GPR89B, AQP1, CPT2, NNT, ARL6IP5, PMPCB, ITGAV, CLCC1, ATP7A, SLC30A7, SLC36A1, KCND1, SLC35C2, KCNK12, CACNA2D3, ZDHHC13, ATP1B2, ATP5F1, TRPC4AP, SLC39A14, SLC5A6, COX7A2L, SLC9A6, NDUFS7, SLC25A19, VDAC3, VDAC2, SLC25A10, XPR1, STOML2, SLC35D1, SLC20A1, COX15, KCNA3, ITPR2, ATP5J, ATP5I, SLC1A4, COX5B, ATP5O, CLCN3, ACACA, ATP5L, RHD, ANKH, ATP6V0A2, SLC38A6, CYC1, SLC25A20, CCL19, KCNN3, APOL1, SLC36A4, NTSR1, ATP6V1F, TIMM8B, SLC35A2, SLC12A2, SLC37A1, ATP13A1, SLC31A1, P2RX7, P2RX4, SFXN3, SFXN4, FXYD5, CALM1, KCNK3]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[PTGER4, CUEDC2, SERPINF1, GPS2, RORA, AGER, NFKB1, IL22RA2, BCR, ABR, NLRP12, ADORA2A, NLRP7, PBK, NLRP3, TEK]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[PTGER4, SUCNR1, FCER1G, ITGA2, PARK7, PIK3CG, NFKBIA, C3, VAMP8, NLRP12, IL6, KARS, IL23A, NPPA, TLR7, CCR2]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, CIB1, TUBA1C, TUBA1B, TUBB6, KIF19, NUF2, ZNF207, FBXO5, NEFH, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KATNAL1, MAP7D1, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, KPNB1, PAFAH1B1, MCPH1, HDAC3, TUBGCP2, VPS4B, TUBD1, CCNB1, SPAST, KIF3B, LMNA, CLASP1, MARK2, BBS2, UBE2B, CEP350, NDC80, RAB11A, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, FES, KIF4A, CENPJ, TBCE, FGFR1OP, SPRY1, CALM1, SPC25]
GO:1904903;ESCRT III complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;38.04764185170599;7.474488534686424;0.0012734203321220245;0.7053660038532718;[VTA1, VPS4B]
GO:0019076;viral release from host cell;7.0;0.8436909121759173;0.7727648213451592;9.387362195675234;33.814119637874356;7.9853141584524145;0.001131728153547711;0.7592887026755414;[VPS4B, PPID]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCL5, CCL19, ARHGEF5, PIK3CG, CCR2]
GO:0050847;progesterone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;7.697632086000634;0.0018077141342769656;0.7686572628545723;[WBP2, UBR5, UBE3A]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[PTGER4, CUEDC2, SUCNR1, CFH, OTUD7B, GPS2, RORA, PARK7, AGER, RELA, PIK3CG, C2, IL22RA2, C3, ABR, NLRP7, C1QBP, CCL5, NPPA, PBK, NLRP3, A2M, CCR2, FCER1G, ITGA2, SERPINF1, NFKB1, BCR, NFKBIA, VAMP8, NLRP12, IL6, KARS, ADORA2A, IL23A, TLR7, TEK, TBC1D23, DNASE1L3, MGLL, C1QC, MCPH1]
GO:0034214;protein hexamerization;6.0;1.0;0.8231203125901445;9.628524252492122;42.032160359171186;7.474488534686424;0.00140677858073304;0.7053660038532718;[SPAST, OAT]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ITGB1, FCER1G, ITGB2, CD9]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[TFRC, SLC22A17, MYC, ATP6V0A2, SFXN3, SFXN4, NEDD8, ACO1]
GO:0010121;arginine catabolic process to proline via ornithine;12.0;1.0;0.9481203125901445;9.628524252492122;685.6044627279941;9.777073627680469;0.022946564363548798;0.9481203125901445;[OAT]
GO:2000780;negative regulation of double-strand break repair;9.0;0.8436909121759173;0.8180860812682478;9.526741558182179;610.9721766560407;6.558197802812269;0.02044868891341728;0.7316271658034954;[POLQ, FBXO18, UBR5, TFIP11]
GO:0034453;microtubule anchoring;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;33.1981629444775;6.558197802812269;0.0011111126373447525;0.6585068532133508;[NIN, CEP350, FGFR1OP, CLASP1]
GO:0031065;positive regulation of histone deacetylation;10.0;0.8933024483968273;0.861892236059334;9.571365838652174;1219.9035963218012;6.8867018697843045;0.04082907552693193;0.7674272657460779;[NIPBL, ING2]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PTPRA, ATP6V0A2, ATP6V1F, IGF1R, APPL1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, CD80, LST1, SIRPG, CIB1, PTPRK, COMT, PKD2, FLCN, ING2, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, ADORA2A, TAX1BP3, B4GALT7, BECN1, STK4, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, MNDA, SPRY1, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[TFRC, CD80, PDCD6, SIRPG, CCNF, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, MYC, FNTB, SOX8, IL12A, SKP2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, FLT3LG, RUNX2, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, CARD11, FOXG1, EBI3, NOLC1, CORO1A, AGER, CCNB1, ABL1, SSR1, NCKAP1L, XBP1, CDC7, CNOT6, IL6, CDK6, CNOT7, SP1, CDK2, FGFR1OP, CNOT8, MNAT1, CD24, CCNJL, ITGB1, CDKN1A, CD40, WDR48, BMPR2, ITGB3, KIF14, LBH, CTSH, ITGAV, ATP7A, HRAS, CCR2, HLA-DPA1, HAVCR2, SPHK2, ITGA2, SPHK1, FCRL3, TBC1D8, ARNT, PDCD1LG2, NME1, KIT, BIRC6, EAPP, HBEGF, HDAC1, DERL2, CRIP2, THBS1, RELA, FZR1, HLA-DMB, CCL5, CCL19, IL12RB1, TBX1, MAP3K3, TSHR, PDCL3, CD4, GPAM, HLA-DPB1, KRAS, FAM98A, TEK]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[CIB1, PARK7, UBE2Z, TM7SF3, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, SERPINF1, FLT3LG, THOC6, NUP93, SFRP1, CFDP1, PPIF, VDAC2, CHMP4B, ADNP, EPHA1, PPID, ABCB4, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, SULT1A3, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, WFS1, NONO, RHBDD1, CAV1, PYCR1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, CDK5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, BRCA1, AATF, PIK3CG, ING2, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, HRAS, TEAD2, TSC22D4, FGA, DFFA, FCER1G, SPHK2, PARP2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, BIRC6, MET, BECN1, HDAC3, HDAC1, VPS4B, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, DCPS, TBX1, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, PSMC1, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:1902731;negative regulation of chondrocyte proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;46.9815665635761;8.67846133901236;0.001572430752218078;0.7669372290569613;[BMPR2]
GO:0061512;protein localization to cilium;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;32.77360880529348;6.139487467954083;0.001096903192380182;0.6370939872166814;[BBS2, ARF4, TMEM107, IFT122]
GO:0001893;maternal placenta development;4.0;1.0;0.75;9.628524252492122;43.252245699280884;7.379178354882098;0.001447613739060994;0.6273715242355574;[RXRA, BMPR2, TMED2]
GO:0070584;mitochondrion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;64.70445744698846;6.781341354126479;0.002165599960519628;0.6370391240755715;[NDUFS6, NUBPL, MTM1]
GO:2000536;negative regulation of entry of bacterium into host cell;6.0;1.0;0.8231203125901445;9.628524252492122;41.24340556955499;9.083926447120524;0.0013803796677578101;0.7876727335416686;[ITGAV]
GO:0072520;seminiferous tubule development;4.0;1.0;0.75;9.628524252492122;49.55861996907746;7.379178354882098;0.0016586824105027187;0.6273715242355574;[ING2, WDR48, TBC1D20]
GO:0015808;L-alanine transport;11.0;0.8933024483968273;0.8790801765280758;9.567899630675686;156.4478742426539;7.8311634786251565;0.005236169556955925;0.8329150168128974;[SLC36A1, SLC1A4, SLC36A4]
GO:0071550;death-inducing signaling complex assembly;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;40.42272244673708;7.697632086000634;0.0013529121422039536;0.6838982747154925;[TRADD, RIPK1]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[PARVG, ITGB3, KIF14, ABL1, ITGAV, TEK, EPHA1]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[STOML2, ATP13A1, CACNA2D3, ITPR2, ATP2A2, PKD2L1, PKD2, TRPC4AP, P2RX7, P2RX4, PMPCB, ITGAV, CCL19]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ITGB3, KIF14, PARK7, STK4, THBS1, STK3, ABL1, NEK1, NCKAP1L, RIPK1, CCL19, ECT2, MARK2, MAP3K3, DUSP5, PRNP, MAP4K2, MAP3K1, PDE6H, ANGPT1, ZFP91, TNFRSF10B, TNFRSF10A, PILRB, OXSR1, MAPK8IP3, ERN1, P2RX7, CCDC88A, KARS, TAOK2, KIT, MADD, ADNP]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[FCRL3, GPS2]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[TM7SF3, AACS, BAIAP3]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[MAP3K3, SCARB1, GPI, CD40, BMPR2, ANGPT1, ROCK2, ITGB3, PDCD6, CIB1, THBS1, P2RX4, SP1, ABL1, TEK, MET]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, STOML2, BTN2A1, PTPN22, BTN3A2, NFKB1, RELA, RC3H2, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, HLA-DPA1, HLA-DQB1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[PRNP, CD40, NCF1, ANGPT1, SEMA4D, ITGB3, CD80, LRP8, CD4, IL6, HSPH1, EHD4, ARL2BP, IL23A, CCL5, KIT, ABL1, IL12A, ADNP, CD24, HBEGF]
GO:2000772;regulation of cellular senescence;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;54.37826267282118;6.250713103064308;0.0018199915144001952;0.6427820713687392;[BCL2L12, MAP3K3, NUAK1, ING2, CDK6, RBL1, ABL1, KRAS, ARNTL]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2CA, ERRFI1, SFRP1, SEMA4D, CAV1, FGFR1OP, CHMP6]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[ANAPC13, CCNF, UBE3A, BRCA1, ANAPC11, UBE2L3, NPEPPS, FZR1, RNF213, RNF138, CDC26, UBR5, TRIM69, RFFL, SKP2, C18orf25, RNF20, UBE2B, DTX3L, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, MARCH6, RC3H2, ITCH, SPSB1, UBE2T, CDC16, FBXL3, ANAPC5, TRIM32, THOP1, RNF166]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[BECN1, BTG2, XBP1, ONECUT2, SECISBP2, PBX3, THOC2, MYO7A, GBA2, FXR1, GNAT2, CDK5, UQCRQ, GNAQ, ATP7A, PAFAH1B1]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[BECN1, GABARAPL1, CDKN1A, XBP1, SEH1L, BMPR2, MAX, CLEC16A, EIF2AK3, COMT, EIF2S1, SFRP1, WRN, TBL2, MARS, LAMP2, PIK3C3, FADS1, CPEB4, ATG5]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[DOCK11, CASP3, ABL1, NCKAP1L, RC3H2]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[EIF2B4, KIT, UBE3A, TAF4]
GO:1903829;positive regulation of cellular protein localization;6.0;0.5960880403619941;0.6211643327711416;7.795942788743812;40.8677261891161;4.050225880093272;0.0013678060169840123;0.5302490524528797;[ITGB1, USP36, YWHAB, ITGB2, CIB1, PARK7, ABCA12, BBC3, UBE2L3, NPEPPS, UBL5, NIPBL, NUP62, GTSE1, HRAS, EMD, FCER1G, DTX3L, TMEM173, YWHAZ, GNL3, TFDP1, TFDP2, RER1, RUFY3, HDAC3, EPB41, ROCK2, TM9SF4, BAG3, TPR, UBR5, VPS11, TP53BP2, LRIG2, ECT2, BID, PRNP, TMEM30A, JUP, EDEM1, EIF2AK3, NDC80, RAB11A, VIL1, CCDC88A, CYLD, GNL3L, CDK5, CAMK1]
GO:0048672;positive regulation of collateral sprouting;11.0;0.8653626801206646;0.8651102923899945;9.55953138100517;1258.1320494776805;7.379178354882098;0.04210854745068503;0.8098004765652196;[SEMA4D]
GO:0050862;positive regulation of T cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.212124270218933;0.01221922354838398;0.7438283705770736;[CYLD, RELA]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[ITGB2, TLR7]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, XBP1, TFRC, PMM1, XRCC5, BSPRY, SRM, BCLAF1, RNF138, PIGA, MTF2, ADAM23, JARID2, NEFH]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[ITGB1, SLC9A6, CDK5, SPG11]
GO:0048311;mitochondrion distribution;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;32.547621880228036;6.943860283624253;0.00108933961337327;0.6453503496879909;[MSTO1, TRAK1, MTM1]
GO:0034435;cholesterol esterification;8.0;1.0;0.875;9.628524252492122;81.04886967978146;8.67846133901236;0.0027126327289351904;0.8188169164668168;[SOAT1]
GO:0050748;negative regulation of lipoprotein metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.474373572664863;288.58086877261815;8.390779266560578;0.00965854197189917;0.7800242071602487;[ITGB3, ITGAV]
GO:2000420;negative regulation of eosinophil extravasation;10.0;1.0;0.9152410118609203;9.628524252492122;705.352472133897;9.777073627680469;0.02360751246630976;0.9152410118609203;[PTGER4]
GO:0033344;cholesterol efflux;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.599019797332524;0.001326765671179004;0.712474179321389;[SCARB1, SOAT1]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[PTGER4, CXCL6, SCARB1, CD40, GFI1, CD80, ABCB4, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, TNIP2]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[ERRFI1, USP8, ABCC2, SERPINF1, ABCB4, DDIT4, AQP1]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[BECN1, SEH1L, VPS4B, KIF14, CDCA8, RAB11A, CENPE, CCNB1, NUP62, CHMP4B, KIF2C, CHMP6, KPNB1]
GO:0034316;negative regulation of Arp2/3 complex-mediated actin nucleation;13.0;1.0;0.9625549647676366;9.628524252492122;474.9356896510967;8.16763571524637;0.01589567011825161;0.8802482350792397;[GMFB]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[NISCH, NCKAP1, ALS2, ELMO1]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[DTX3L, EPB41, CAV1, PARK7, TMEM173, STK4, STK3, PPP2CA, GNL3L, CDK5, ABL1, EP300, MAPRE3, TRIB3, MAPRE1, DACT1]
GO:0035360;positive regulation of peroxisome proliferator activated receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;7.697632086000634;0.006257069970731893;0.7445766281117727;[STARD10, ASXL2, GPS2]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[TLR7, HAVCR2]
GO:0045445;myoblast differentiation;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;6.599019797332524;7.050676185779127E-4;0.587474179321389;[MBNL1, MAML1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SMG1, STK4, IGF1R, MKNK2, TRIM24, ABL1, RIPK1, CSK, MARK2, EPHB4, PDGFRB, MAP3K3, CAD, EIF2AK3, VRK1, VRK2, CLK4, EIF2S1, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, TAOK2, KIT, TEK, EPHA1, CSNK1G2]
GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.417215158824915;234.05310184950287;6.113511981550823;0.00783354668478672;0.6876452870438905;[ERRFI1, SH3KBP1, NUP62, SPRY1, CHMP6]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[PTGER4, OXTR, YWHAB, GPS1, IL5RA, GPS2, STK4, RASGRP4, STK3, PABPN1, CCL5, MYC, CTSH, NEK1, NCAM1, MBP, RIPK1, ITGAV, HRAS, SULT1A3, PDGFRB, MAP3K3, DUSP5, MAP4K2, MAP3K1, KSR1, ANGPT1, PAQR3, OXSR1, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, KIT, CCM2, KRAS, TEK, CALM1, MET, HBEGF]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[P2RX7, CASP3, NCKAP1L, CORO1A, RC3H2]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[RHEB, ZNF365]
GO:0060964;regulation of gene silencing by miRNA;8.0;0.7369933605727446;0.7434966802863723;9.158520623246385;63.198578554006836;5.8067817141283475;0.0021151995491745495;0.6719590869034888;[FXR1, NCOR2, IPO8, NCOR1, POLR2B, H3F3A, POLR2E, POLR2G, TNRC6A, PUM2]
GO:0002675;positive regulation of acute inflammatory response;8.0;0.7090535922965819;0.729526796148291;8.971744716103052;164.518653823802;6.518977089658987;0.005506291286306897;0.7083807915285978;[C3, IL6, FCER1G, PARK7, PIK3CG]
GO:0000381;regulation of alternative mRNA splicing, via spliceosome;10.0;1.0;0.9152410118609203;9.628524252492122;185.80693659341267;5.649939242635378;0.00621879095239513;0.704179167478338;[PTBP1, MBNL1, WTAP, SAP18, RBM5]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[CSNK2A1, PLAUR, TNFRSF10B, TNFRSF10A, NLRC4, PARK7, UBE2Z, THBS1, AQP1, VIL1, BCL2L12, ADORA2A, BIRC6, RFFL]
GO:1990603;dark adaptation;9.0;1.0;0.896240625180289;9.628524252492122;82.7304698495867;9.777073627680469;0.0027689143732766734;0.896240625180289;[PAPD4]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[DIABLO, PDCD6, TRADD, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, CASP3, NLRP3, CTSH, RIPK1, BID]
GO:0036324;vascular endothelial growth factor receptor-2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;32.61172235596797;9.083926447120524;0.001091484998609603;0.8607930461318132;[PDCD6]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[ITGB1, AKAP13, RXRA, ARID1A, SOX6]
GO:0055129;L-proline biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;721.3825385994909;8.16763571524637;0.024144024364789993;0.8501222226412654;[OAT, PYCR1]
GO:2000312;regulation of kainate selective glutamate receptor activity;10.0;1.0;0.9152410118609203;9.628524252492122;462.3570184446122;8.67846133901236;0.0154746733130397;0.8590579283277371;[NETO2, KLHL24]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[RTKN, RCC2, GPS1, PDE6D, TMED2, ARL2, GPS2, SPRY1, IQGAP2, HRAS]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[NFKBIA, CYLD, ITCH, NLRP12, BRMS1, ADORA3, GFI1, NLRP2, NLRP3, COMMD1, HAVCR2]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[USP8, SFRP1, JUP, TBL1XR1, CAV1, USP34, UBR5, NFKB1, ARNTL, DACT1]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[CYLD, SFRP1, XBP1, FCRL3, NCKAP1L, CARD11]
GO:0045214;sarcomere organization;7.0;1.0;0.8509193652572005;9.628524252492122;33.95844942788184;6.063501560976162;0.0011365587417308835;0.6610071170671804;[ITGB1, WDR1]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[ITGB3, ITGAV]
GO:0060712;spongiotrophoblast layer development;4.0;1.0;0.75;9.628524252492122;49.67194865438347;7.697632086000634;0.0016624754196107158;0.6436572628545723;[BIRC6, SENP2]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[SEMA6B, SEMA4D]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4, PPP2R2A, RELA]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[BMPR2]
GO:0060836;lymphatic endothelial cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;25.300332287391186;7.9853141584524145;8.467793528382013E-4;0.7314896500084853;[BMPR2]
GO:0045337;farnesyl diphosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.585964638073326;561.3122105398157;8.390779266560578;0.018786614538575143;0.8041048419030481;[GGPS1]
GO:0060711;labyrinthine layer development;4.0;1.0;0.75;9.628524252492122;34.608406302298;7.697632086000634;0.001158312213394382;0.6436572628545723;[BIRC6, SENP2]
GO:1902916;positive regulation of protein polyubiquitination;11.0;0.8436909121759173;0.8542744084176208;9.519324960527129;611.6426321926975;7.474488534686424;0.020471128456858376;0.8146746435927894;[PTPN22, SKP2, RNF40]
GO:0045581;negative regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;878.9850552837634;6.088194173566533;0.029418838765156156;0.7075911583464645;[CYLD, IL4R, CTLA4, RC3H2]
GO:0043162;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;9.0;1.0;0.896240625180289;9.628524252492122;157.5507831317809;7.004484905440688;0.005273082924921447;0.7544503089863854;[VPS4B, VPS37A]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[ITPKB, CYLD, XBP1, IL4R, IL23A, CD80, NLRP3, NCKAP1L, IL12A, CCL19, IL12RB1]
GO:0034379;very-low-density lipoprotein particle assembly;7.0;1.0;0.8509193652572005;9.628524252492122;106.00255471231415;7.474488534686424;0.003547810110115553;0.7331650565203278;[SOAT1]
GO:2000320;negative regulation of T-helper 17 cell differentiation;13.0;0.9326813400603323;0.9288956347978027;9.611994950540911;2655.6849744475344;7.57984905034425;0.0888833861334514;0.8501887977012701;[RC3H2]
GO:0034378;chylomicron assembly;7.0;1.0;0.8509193652572005;9.628524252492122;106.00255471231415;7.474488534686424;0.003547810110115553;0.7331650565203278;[PLAGL2]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[UBR5, TMEM173]
GO:2000582;positive regulation of ATP-dependent microtubule motor activity, plus-end-directed;7.0;1.0;0.8509193652572005;9.628524252492122;134.42213444296092;8.16763571524637;0.004498987867739075;0.7686126355688037;[DYNLL2, DNAL4]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, PAXIP1, CAV1, GLMN, CCM2, ITGAV, RASIP1, TEAD2]
GO:0045109;intermediate filament organization;6.0;0.8933024483968273;0.7697715367885581;9.523163736834295;46.579145119294324;6.641579411751319;0.0015589620686337537;0.6627709925721352;[KLHL24, NEFH, MTM1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFKB1, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:0045595;regulation of cell differentiation;4.0;0.3376379861120121;0.41881899305600606;5.249000748036359;23.33457331431992;2.3564947222696686;7.809871690777242E-4;0.3705112496850823;[ERRFI1, PLEKHB2, MAML1, GFI1, CD80, PLEKHB1, CIB1, RORA, AQP3, CYB5D2, EIF4ENIF1, PPP1CC, KIAA1109, MYC, CFL1, EP300, SOX8, IL12A, SOX6, FADS1, SEMA6B, IL4R, IGFBP5, SERPINF1, PAQR3, FLT3LG, THOC2, UNC13D, RUNX2, PIAS2, RC3H2, OLFM1, EID1, SFRP1, TWSG1, IL23A, RUFY3, HOXB4, TRIB3, ADNP, FKBP4, CARD11, ANKRD17, FOXG1, STK4, SUPT6H, AGER, GLG1, STK3, FXR1, NCKIPSD, ABL1, DVL3, NLRP3, NCKAP1L, RIPK1, ECT2, MARK2, S100A10, TFAP2A, CREBBP, PRELID1, XBP1, XRCC5, CAV1, RCC2, H3F3A, IDH2, SSH3, NFKB1, SETX, CDK9, NFKBIA, CCDC88A, CYLD, IL6, CDK6, SYNJ1, ARPC2, COL5A1, CDK5, FES, RHEB, GNAQ, CAPRIN1, MAFF, SCGB3A1, CD24, EZH2, ITGB1, SETD3, BMPR2, BTG1, WDR1, ITGB3, KIF14, IL27, FLCN, AKAP13, PTBP1, NIPBL, LBH, SIN3A, C1QBP, KIF13B, CTLA4, ITGAV, HIF1AN, SCARF1, TEAD2, ZNF365, CCR2, FGA, ACTR2, KLF13, RBM15, PARP2, FCRL3, FGG, ARNT, SIRT2, MED28, NME1, GAK, ITPKB, GAL, IRF4, KIT, PAFAH1B1, HEMGN, HDAC1, ROCK2, GPS2, TRAK1, LRP8, THBS1, RELA, ARNTL, RAB21, PPP2CA, RBBP5, TP53INP1, LRIG2, CCL19, IL12RB1, CLASP1, TCFL5, TBX1, SPEN, TMEM30A, SEMA4D, TMEM176A, GPR55, GRHL1, LILRB3, RAB11A, MIB1, PER2, ITCH, CD4, CAMK4, ASXL2, ACIN1, KRAS, CAMK1, TRIM32, SMAP1, MIXL1, TNRC6A, C1QC, LIMS1]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[RBM15, STK4]
GO:0045596;negative regulation of cell differentiation;5.0;0.44223782556504454;0.5113599246434426;6.502738850689933;82.78823984741369;3.2727854541438237;0.0027708478831143203;0.4576114121859235;[ITGB1, ITGB3, GFI1, CIB1, RORA, EIF4ENIF1, PTBP1, LBH, MYC, CTLA4, SOX8, ITGAV, SOX6, ZNF365, SEMA6B, IL4R, KLF13, RBM15, IGFBP5, PAQR3, THOC2, SIRT2, RC3H2, MED28, NME1, GAK, ITPKB, SFRP1, TWSG1, GAL, RUFY3, TRIB3, FKBP4, PAFAH1B1, ANKRD17, FOXG1, GPS2, ARNTL, PPP2CA, TP53INP1, LRIG2, TBX1, XBP1, SEMA4D, CAV1, RCC2, TMEM176A, IDH2, GPR55, LILRB3, MIB1, NFKBIA, CYLD, IL6, CDK6, COL5A1, CDK5, KRAS, MIXL1, C1QC, EZH2]
GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.56183287799345;487.9171050824184;6.481236761676141;0.016330146410222554;0.7795710619905949;[NFKBIA, CYLD, ITCH, RELA]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[DUSP5, EYA2, DUSP28, PTPN22, PTPRK, SSH3, CDC25A, DUSP14, MTM1, PTP4A1, DUSP22, DUSP23, PTPRA]
GO:0072719;cellular response to cisplatin;6.0;1.0;0.8231203125901445;9.628524252492122;120.46332589257861;8.16763571524637;0.004031799107669873;0.7408135829017477;[SLC31A1, TIMELESS]
GO:0034244;negative regulation of transcription elongation from RNA polymerase II promoter;12.0;1.0;0.9481203125901445;9.628524252492122;4178.882431846446;7.379178354882098;0.13986343424388045;0.825491836825702;[EAPP, EZH2]
GO:0031098;stress-activated protein kinase signaling cascade;6.0;0.7980440201809971;0.722142322680643;9.193206181234276;55.4262366053078;5.142344639450834;0.0018550662588052154;0.5861000565951415;[PTGER4, MAP3K3, MAP4K2, MAP3K1, GPS1, GPS2, OXSR1, STK4, NFKB1, STK3, TNIP2, TAOK2, NEK1, CCM2]
GO:0090367;negative regulation of mRNA modification;9.0;1.0;0.896240625180289;9.628524252492122;456.9714116798257;9.777073627680469;0.015294421901353706;0.896240625180289;[BAG4]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[IRF4, UBQLN1, GPS2, LILRA2]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[RPL3, GMFB, MAML1, PSMD8, PSMD7, PSMD4, PSMD2, MYC, CSNK2A1, PRKAB1, RC3H2, BCR, PSME2, RPL29, ANAPC13, CDCA3, RPN1, COPS7B, COPS7A, ANAPC11, C3, RHOT1, RNF213, SULT1A3, ATG5, CREBBP, PMM1, ABCA3, EDEM1, H3F3A, PMM2, EIF2AK3, LNPEP, CDC7, ERLIN2, PGA3, RPL3L, PGA5, SETX, CYLD, RNF103, EZH2, CPEB4, PIGS, ARF4, BTG2, SMG1, PIGU, WDR48, PIGT, SETD3, BTG1, SERPINA10, CLTA, MRPL37, TRIM9, UBL5, TRIM7, PBK, PCMTD1, DUSP5, JOSD1, SIRT2, CIT, DDB1, ITPKB, PSMA1, PIGA, MED20, RNF166, HBEGF, GPS1, GPS2, PSMA7, GGA3, PSMB5, RNF138, PSMB1, AP2S1, HARS, APOL1, RPL19, EGLN2, SYVN1, GTF2H4, SPSB1, PSMC1, RFWD3, TAOK2, RPL22L1, RAB3B, IL5RA, STK19, YEATS4, PARK7, YY1, PPP1CB, PPP1CC, NPEPPS, FNTB, LAMP2, CFL1, NEK1, PMPCB, C18orf25, USP8, RPS9, RNF44, FBXO18, IGFBP5, RPS7, VPS33B, SARS, VRK1, VRK2, CDC25A, PIAS2, RNF40, MINPP1, ILF3, ANAPC5, FKBP4, CSNK1G2, CSNK1G1, UBR4, PKMYT1, RLF, HSP90B1, MTM1, STK35, MED30, STK38, UBR5, ABL1, MBP, RAB6A, DR1, TOR1A, SDF2L1, AMBP, WFS1, BRPF3, BTBD6, MARCH6, NFKB1, MARCH3, CDK9, CNOT4, COPS5, CDK6, CDK5, UBLCP1, YEATS2, PTPRA, CDK2, FGFR1OP, MNAT1, BMPR2, PTPN22, MSLN, PIK3CG, DUSP14, PPP6C, SIN3A, SUMO3, PGM3, TRIM69, ITGAV, HIF1AN, ATP7A, KSR1, DTX3L, ZFP91, DUSP28, RAD23A, SPTB, RABGGTA, PTP4A1, DUSP22, DUSP23, ADORA2A, CTDSP2, PIK3C3, ETF1, BIRC6, MET, BECN1, HDAC3, ITIH2, HDAC1, ROCK2, MGRN1, RNF38, NLRC4, PPM1G, FZR1, RBBP5, CCL5, SAP18, CSK, RBBP7, RFFL, SEC11A, SEC11C, RNF20, NDUFA7, ANGPT1, FEM1B, FBXL15, RPL23A, FBXL16, P2RX7, SNRK, DOLPP1, TSPAN17, RAB13, MGAT4B, ASXL2, CCM2, TRIM32, TRIM33, METAP2, OXTR, CCNK, CCNH, CCNF, ZDHHC5, ZDHHC6, PPP2R2A, UBE2L3, RPS6KA4, RPS15, HERC4, RPS6KA5, HERC1, RPL36AL, RPS6KA2, CDC26, TRIM24, SKP2, SEPHS1, EPHB4, ST6GAL1, ESCO1, ARRDC1, SLC35C2, COG3, NSMCE2, PAQR3, SLC35C1, MRPS18B, ALG2, MRPS18A, ALG1, KARS, KCTD10, TRIB3, EPHA1, CBLL1, PAXIP1, FUT11, MYCBP2, LIAS, TGOLN2, NUAK1, HLTF, STK38L, ZBED1, RPL39L, SETDB1, BCL11A, KLHDC8A, CDC16, CALU, FBXL3, CALM1, HBS1L, MRPS16, PPP1R11, FASTKD1, GPAA1, SUV39H1, OTUD7B, BRCA1, PTPRK, AKAP13, ZMYM2, CTSH, HRAS, VKORC1, MAP4K2, MRPS24, PARP2, PRMT3, COMMD1, GFRA2, GAK, PDIK1L, KIT, FASTKD5, TLR7, MRRF, PTGER4, CSTA, PCNA, MRPS36, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, PPP2CA, PDPR, MGAT3, MGAT1, UBL4A, MAP3K3, MAP3K1, DOHH, RAB11A, MIB1, PER2, ITCH, SPCS2, CAMK4, KBTBD2, CAMK1, KBTBD8, GALNT12, DPAGT1, GALNT11, CRTC2, ARID4A, BUB1B, UBE3A, UBE2Z, GALNT10, IGF1R, PPME1, NPPA, EP300, TGM6, SBF1, PDGFRB, SSU72, TRPC4AP, ERN1, DPM3, BRMS1, TBL1XR1, CCNE1, RPL7L1, PPIF, PPID, HIST1H2BC, DTX2, KLHL12, STK4, RASGRP4, FUT4, STK3, VCPIP1, CCNB1, FUT8, UBD, NLRP3, USP51, RIPK1, SUDS3, MARK2, UBE2I, UBE2B, KLHL25, CBX4, RHBDD1, DOLK, KLHL24, CLK4, SSH3, EIF2S1, CLK3, CLK1, NFKBIA, IL6, PAN3, TMEM115, MAN2B2, FES, UBE2T, STT3A, MAN2B1, USP36, USP37, USP38, PRKCSH, MAST3, USP32, YWHAB, USP34, USP39, GPHN, SENP6, POLB, USP46, FGA, FGG, CAD, PPP2R5D, OXSR1, SENP2, MASTL, IRF4, MAN1B1, USP41, B4GALT7, THOP1, STOML2, HIST1H2BO, HIST1H2BJ, USP12, RRBP1, THBS1, PSMB10, TFPT, PABPN1, RAB40C, MKNK2, NCAM1, MTA2, EYA2, GALNT1, POLE4, WEE1, TNIP2, ASB8, POLE3, KRAS, FAM98A, TAF5, TEK, ASB3]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[IL6, GPS2, RORA, TRIB3, SIRT2, ARNTL]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR7]
GO:0046329;negative regulation of JNK cascade;12.0;0.9326813400603323;0.9144609826203107;9.607904965289386;1764.4523437695266;6.280566066213989;0.05905463204195212;0.7693087532925187;[ITCH, SFRP1, HDAC3, NCOR1, AMBP, GPS2, PTPN22, PAFAH1B1, DACT1]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR7]
GO:0000245;spliceosomal complex assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;66.59596265062147;6.444869117505266;0.002228906937441061;0.6805102716434839;[SNRPG, USP39, SF3B1, RBM5]
GO:0042093;T-helper cell differentiation;10.0;0.8436909121759173;0.837086467948879;9.485423408851448;472.3173309007748;6.943860283624253;0.015808036007248224;0.7703503496879909;[PTGER4, BCL3, RORA, ATP7A, RC3H2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, PPIF, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, BRCA1, AATF, PIK3CG, ING2, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, BIRC6, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[P2RX7, CD151, IL23A, ELF4, DOCK8, EBI3, ABL1, DOCK2, RC3H2, PIK3CG]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, ITGB1, CD40, BTG1, YWHAB, PDCD6, TRADD, PARK7, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, MYC, CASP3, ARL6IP5, CASP2, CTSH, CTLA4, IL12A, RBM5, PDGFRB, KLF11, DFFA, C3orf38, ENDOG, FBXO18, RPS7, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, VAV2, SFRP1, GAL, BRMS1, TFDP1, TFDP2, ADORA2A, PTRH2, PPIF, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, STK4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP2, ABL1, NLRP3, SAP18, PLAGL2, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, G0S2, TNFRSF10B, TNFRSF10A, HSPE1, EIF2S1, P2RX7, CYLD, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ADORA2A, ITGB3, CDC7, ITGAV, CORO1A, MET, TM9SF4, UNC13D]
GO:0070534;protein K63-linked ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;157.60047254366168;6.166155715036245;0.00527474598481953;0.747766442352181;[ITCH, UBE2B, UBE2T, ZFP91]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YWHAB, CASP3, STK4, TEAD2, STK3, TJP2]
GO:0006907;pinocytosis;6.0;0.7980440201809971;0.722142322680643;9.271849308553389;28.437470009997963;7.379178354882098;9.517765291732001E-4;0.7004918368257019;[EHD4, DOCK2]
GO:0070536;protein K63-linked deubiquitination;10.0;0.9326813400603323;0.8815816818910864;9.577230958104572;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[USP8, CYLD, OTUD7B]
